8-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 5, 2003

HEI, Inc.
(Exact name of Registrant as Specified in Charter)

Minnesota	0-10078	41-0944876
(State or Other Jurisdiction	(Commission	(IRS Employer
of Incorporation)	File Number)	Identification No.)

6385 Shady Oak Road, Suite 280, Eden Prairie, MN 55344
(Address of Principal Executive Offices, including Zip Code)

(952) 443-2500
(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

TABLE OF CONTENTS

EX-99.1 Press Release dated January 24, 2003

EX-99.2 Press Release dated January 28, 2003

EX-99.3 Press Release dated January 28, 2003

EX-99.4 Information from Presentation-Fant

EX-99.5 Information from Presentation-Hawksworth

Item 9.  REGULATION FD DISCLOSURE.

     On January 24, 2003, HEI, Inc (“HEI”) issued a press release announcing the acquisition of the Colorado operations of Colorado MEDtech, Inc. (“CMED”). On January 28, 2003, HEI issued press releases providing additional information regarding the acquisition of the Colorado operations of CMED and announcing a conference call to be held on January 28, 2003, at 4:30 p.m. (Eastern Time) to discuss the acquisition of the Colorado operations of CMED. Copies of these press releases are attached to this Current Report on Form 8-K as Exhibits 99.1, 99.2 and 99.3, respectively.

     On February 5, 2003, at the HEI, Inc. Annual Meeting of Shareholders (the “Annual Meeting”), each of Anthony J. Fant, the Chairman, Chief Executive Officer and President of HEI, and Simon F. Hawksworth, Vice President of Sales and Marketing of HEI, delivered presentations. The information contained in the presentation by Mr. Fant is attached to this Current Report on Form 8-K as Exhibit 99.4, and the information contained in the presentation by Mr. Hawksworth is attached to this Current Report on Form 8-K as Exhibit 99.5.

     Mr. Fant announced at the Annual Meeting that, effective January 24, 2003, HEI issued a Subordinated Promissory Note (the “Note”) to CMED in exchange for a loan in the amount of $2.6 million. The interest rate on the Note is currently 10%, increasing by 2% in July 2003 and January 2004. The principal and interest are due under the Note on September 30, 2004. Mr. Fant also announced that the $2.6 million loaned to HEI by CMED was used, in part, to pay all debt owed to LaSalle Business Credit, Inc., under that certain Amended and Restated Revolving Note, dated effective December 1, 2002.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		HEI, INC.
Dated:	February 6, 2003	By		/s/ Steve E. Tondera, Jr.
			Steve E. Tondera, Jr.
			Its:	Chief Financial Officer, Treasurer, Vice
				President Finance and Secretary

Exhibit Index

Item No.	Description
99.1	Press release dated January 24, 2003.
99.2	Press release dated January 28, 2003.
99.3	Press release dated January 28, 2003.
99.4	Information from Presentation by Anthony J. Fant
99.5	Information from Presentation by Simon J. Hawksworth

EX-99.1 3 c74553exv99w1.txt EX-99.1 PRESS RELEASE DATED JANUARY 24, 2003 EXHIBIT 99.1 NEWS RELEASE [LOGO] HEI INC 6385 Old Shady Oak Road Eden Prairie, Minnesota 55344 USA 952-443-2500 CONTACTS: FOR IMMEDIATE RELEASE Anthony J. Fant, CEO Steve E. Tondera, CFO HEI, INC. ACQUIRES MEDICAL DEVICE DEVELOPMENT AND MANUFACTURING BUSINESS FROM COLORADO MEDTECH, INC. Minneapolis, MN. and Boulder, CO.- January 24, 2003 -- HEI, Inc. (Nasdaq: HEII) and Colorado MEDtech, Inc. (Nasdaq: CMED) today jointly announced that HEI has acquired the Colorado Operations of Colorado MEDtech in a transaction creating a global medical component design and manufacturing outsource business. HEI noted that integrating Colorado MEDtech's Colorado operations with HEI will result in a business that will be a strong contributor to HEI's overall results. HEI said the agreement is expected to enhance HEI's long-term earnings and financial position. In consideration for HEI stock and subordinated debt, HEI has acquired the products, technology and facilities related to Colorado MEDtech's advanced medical technology development and manufacturing business. The transaction does not include Colorado MEDtech's Kalona, Iowa based CIVCO Medical Instrument business unit, which provides medical imaging products and accessories to the ultrasound market. HEI estimates that the acquired business will have revenue somewhere between $20-$25 million for calendar year 2003 and is projecting that it will be accretive to earnings per share - impacting HEI's earnings per share in the second quarter of its fiscal year 2003. "I am very pleased that an agreement has been reached with Colorado MEDtech," said Anthony Fant, CEO of HEI. "HEI and Colorado MEDtech's Boulder division present an extraordinarily good fit from the standpoint of customer and technology synergies. By combining these businesses we can achieve a strong competitive status worldwide without overlaps. The company that will emerge will be uniquely equipped to meet out customers needs in the 21st Century. HEI has been involved in the design and production of microlectronics circuits and products for the medical and hearing business for over 35 years. This acquisition makes us one of world's leading medical component design and manufacturing outsource businesses. This market remains stable and we believe that this acquisition will position us for substantial revenue growth and profits as the trend to outsourcing continues to gain momentum in the medical technology market. The consolidation of the operations and the restructured workforce will greatly reduce costs and will prove to be a springboard for exciting new business opportunities. This transaction provides a truly progressive move for both our businesses. We are extremely excited by what we view as a tremendous opportunity for growth." "This transaction is important because it should provide a smooth transition for clients, who will be able to continue their important work with their project teams," said Stephen K. Onody, President and CEO of Colorado MEDtech. "The conclusion of this transaction is a part of Colorado MEDtech's continuing plan to maximize shareholder value." ThinkEquity Partners, LLC acted as financial advisor to HEI, Inc. Colorado MEDtech was advised by Tri-Artisan, LLC. ABOUT HEI, INC HEI, Inc. specializes in the design and manufacture of high performance, ultra miniature microelectronic devices and high-technology products incorporating those devices. HEI contributes to its customers' competitiveness in the hearing, medical, communications, wireless and contact smart cards, other RF applications, and industrial markets through innovative design solutions and by the application of state-of-the art materials, processes and manufacturing capabilities. ABOUT COLORADO MEDTECH, INC Colorado MEDtech, Inc., through its CIVCO Medical Instruments Co., Inc. subsidiary, is a full service developer and manufacturer of medical devices and equipment for the ultrasound and minimally invasive OEM and end-user markets. HEI'S FORWARD-LOOKING STATEMENTS: Information in this news release, which is not historical, includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements contained in this press release, including the growth of specific markets, improved competitiveness or results and the estimated HEI revenue, cash flow and profits, are forward looking statements. All of such forward-looking statements involve risks and uncertainties including, without limitation, adverse business or market conditions, the ability of HEI to secure and satisfy customers, the availability and cost of materials from HEI's suppliers, adverse competitive developments, change in or cancellation of customer requirements, and other risks detailed from time to time in HEI's SEC filings. COLORADO MEDTECH'S FORWARD-LOOKING STATEMENTS The statements in this news release are not historical facts, including those regarding strategic alternatives, are forward-looking statements that represent management's beliefs and assumptions based on currently available information. Forward-looking statements can be identified by the use of words such as "believes," "intends," "estimates," "may," "will," "should," "anticipated," "expected" or comparable terminology or by discussions of strategy. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot assure that these expectations will prove to be correct. Such statements involve risks and uncertainties including, but not limited to, the risk that the Company may not be able to successfully complete one or more transactions identified in its exploration of strategic alternatives, the risk that the Company's existing level of orders may not be indicative of the level or trend of future orders, the risk that the Company may not successfully complete the work encompassed by current or future orders, the risk that unforeseen technical or production difficulties may adversely impact project timing and financial performance, the risk of an adverse result in pending or potential litigation, the risks associated with regulation by the Federal Food and Drug Administration including compliance with the Quality System Regulation, the risk that acquired companies cannot be successfully integrated with the Company's existing operations and the risk that a downturn in general economic conditions or customer budgets may adversely affect research and development and capital expenditure budgets of potential customers upon which the Company is dependent. Should one or more of these risks materialize (or the consequences of such a development worsen), or should the underlying assumptions prove incorrect, actual results could differ materially from those forecasted or expected. These factors are more fully described in the Company's documents filed from time to time with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update publicly or revise such statements whether as a result of new information, future events or otherwise. EX-99.2 4 c74553exv99w2.txt EX-99.2 PRESS RELEASE DATED JANUARY 28, 2003 EXHIBIT 99.2 NEWS RELEASE [LOGO] HEI INC 6385 Old Shady Oak Road Eden Prairie, Minnesota 55344 USA 952-443-2500 CONTACTS: FOR IMMEDIATE RELEASE Anthony J. Fant, CEO Steve E. Tondera, Jr., CFO HEI UNVEILS NEW MEDICAL ACQUISITION Minneapolis - January 28, 2003 -- HEI, Inc. (Nasdaq: HEII) has acquired the Colorado Operations of Colorado MEDtech, Inc. (Nasdaq: CMED), adding a leading medical equipment, design and manufacturing division to its existing microelectronics design and manufacturing capabilities. The new division based in Boulder, Colorado, specializes in medical technology outsourcing services, including device and software development, medical device connectivity and manufacturing system components for medical imaging. In consideration for 1 million shares of HEI common stock, it acquired approximately $7 million in assets at book value and excluding certain adjustments, will recognize a gain in excess of $1 million in the current quarter. The assets include: intellectual property, equipment, inventory and the facilities of Colorado MEDtech's advanced medical technology development and manufacturing business. HEI estimates this business will add revenue of between $20-$25 million for calendar year 2003. In connection with the purchase HEI will add key research and development staff as well as professionals in process engineering, marketing, product management and assembly. HEI anticipates the combination of the Colorado operations with its Microelectronics and High Density Interconnect divisions to have a positive impact on its overall financial results. The transaction roughly doubles the size of the company with: o Combined revenue of over $50 million for calendar year 2003. o Expected accretive to earnings to the current quarter and forward. o HEI will have approximately 250 employees in 3 locations within the U.S. o Expected gain in the current quarter in excess of $1 million from this transaction. "We view this acquisition as an important milestone in the execution of our strategic plan to add discerning technology to our business. With this move we are better positioned to leverage our capabilities and facilities in a new market for both the design and manufacturing of complex components and subsystems in the medical equipment market. The customers and business of this new division balances nicely with our hearing, medical implantable, industrial and telecom customers," said Anthony Fant, CEO of HEI. CONFERENCE CALL: HEI will host a conference call at 4:30 p.m. EST, Tuesday, January 28, 2003 to discuss this transaction. This call is being webcast and can be accessed in the investor's section of HEI's web site at www.heii.com. The call will be recorded and be available after the call at this same location on the web page THINKEQUITY PARTNERS, LLC ACTED AS FINANCIAL ADVISOR TO HEI, INC. FOR THIS TRANSACTION. - -------------------------------------------------------------------------------- ABOUT HEI HEI, Inc. specializes in the design and manufacture of high performance, ultraminiature microelectronic devices and high-technology products incorporating those devices. HEI contributes to its customers' competitiveness in the hearing, medical, communications, wireless, RF identification, and industrial markets through innovative design solutions and by the application of state-of-the art materials, processes and manufacturing capabilities. For more information, visit www.heii.com. Corporate Headquarters 6385 Old Shady Oak Road, Suite 280, Eden Prairie, MN 55344 Microelectronics Division PO Box 5000, 1495 Steiger Lake Lane, Victoria, MN 55386 Medical Device Development and Manufacturing 4801 North 63rd Street, Boulder, CO 80301 High Density Interconnect Division 610 South Rockford Drive, Tempe, AZ 85281 RF Identification and Smart Card Division 1546 Lake Drive West, Chanhassen, MN 55317 - -------------------------------------------------------------------------------- FORWARD LOOKING INFORMATION Information in this news release, which is not historical, includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All of such forward-looking statements involve risks and uncertainties including, without limitation, adverse business or market conditions, the ability of HEI to secure and satisfy customers, the availability and cost of materials from HEI's suppliers, adverse competitive developments, change in or cancellation of customer requirements, and other risks detailed from time to time in HEI's SEC filings. EX-99.3 5 c74553exv99w3.txt EX-99.3 PRESS RELEASE DATED JANUARY 28, 2003 EXHIBIT 99.3 NEWS RELEASE [LOGO] HEI INC 6385 Old Shady Oak Road Eden Prairie, Minnesota 55344 USA 952-443-2500 CONTACTS: FOR IMMEDIATE RELEASE Anthony J. Fant, CEO Steve E. Tondera, Jr., CFO HEI, INC. ANNOUNCES ACQUISITION OF MEDICAL COMPANY CONFERENCE CALL MINNEAPOLIS--January 28, 2003--HEI, Inc. (Nasdaq: HEII, www.heii.com) will hold a conference call to discuss its acquisition of the Colorado operations of Colorado MEDtech, Inc., (Nasdaq: CMED, www.cmed.com) on Tuesday, January 28, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). The acquisition includes the RELA and IPS divisions of Colorado MEDtech, Inc. This call is being webcast and can be accessed in the investors section of HEI's website at www.heii.com. The call will be recorded and be available after the call at this same location on the web page. The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com. CONTACT INFORMATION: For more information, please contact Steve E. Tondera, CFO, at 952-443-7053. - -------------------------------------------------------------------------------- ABOUT HEI HEI, Inc. specializes in the design and manufacture of high performance, ultraminiature microelectronic devices and high-technology products incorporating those devices. HEI contributes to its customers' competitiveness in the hearing, medical, communications, wireless, RF identification, and industrial markets through innovative design solutions and by the application of state-of-the art materials, processes and manufacturing capabilities. For more information, visit www.heii.com. Corporate Headquarters 6385 Old Shady Oak Road, Suite 280, Eden Prairie, MN 55344 Microelectronics Division PO Box 5000, 1495 Steiger Lake Lane, Victoria, MN 55386 Medical Device Development and Manufacturing 4801 North 63rd Street, Boulder, CO 80301 High Density Interconnect Division 610 South Rockford Drive, Tempe, AZ 85281 RF Identification and Smart Card Division 1546 Lake Drive West, Chanhassen, MN 55317 - -------------------------------------------------------------------------------- EX-99.4 6 c74553exv99w4.htm EX-99.4 INFORMATION FROM PRESENTATION-FANT

Exhibit 99.4

2003 Annual Shareholders Meeting February 5, 2003 Forward Looking Statements: Information in this presentation, which is not historical, includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements contained in this presentation, including the growth of specific markets, improved competitiveness or results, future customer contracts or relationships and estimated revenue, cash flow and profits, are forward looking statements. All such forward looking statements involve risks and uncertainties including, without limitation, adverse business or market conditions, the ability of HEI to secure and satisfy customers, the availability and cost of materials from HEI's suppliers, adverse competitive developments, change in or cancellation of customer requirements, and other risks detailed from time to time in HEI's SEC filings.

Transaction Overview HEI acquired specified assets of the RELA and IPS divisions (the "Colorado Operations") of Colorado MEDtech, Inc. ("CMED") Acquired assets All of the fixed assets of the Colorado Operations $2.5 million of cash, plus additional cash to cover the customer deposit liabilities The inventory (> $3 million), prepaid expenses and lease deposit (> $100k) Includes the Eagle Technology and Link-It Technology and all other Intellectual Prooperty. Assumed liabilities The operating lease for the Boulder, CO facility (150,000 square feet) Customer deposits Accrued warranty Key financial statistics Immediately accretive Results in gain on transaction of approximately of $2.8 million, excluding fees Timing Closed the purchase on January 24th. Results from January 24th-March 1st will be included in our Second Quarter ending March 1st.

Strategic Rationale Enhances financial profile Immediately accretive Doubles HEI's revenue base and adds diversity to revenues Results in gain on transaction of approximately of $2.8 million, excluding fees Strengthens technology leadership Adds significantly to HEI's engineering and design capabilities Provides HEI with software engineering capabilities to support expansion to HEI's existing customer base Vertical expansion of HEI's business The combination of HEI and the Colorado Operations will result in numerous synergies that will support the combined entity's goal of providing a one-stop solution for all customers Horizontal expansion of HEI's business Provides Class III medical manufacturing capabilities The Link-iT technology represents a very attractive new technology linking the functions inside a hospital with the hospital's Information Management System. Provides pilot medical manufacturing capabilities Provides platform for future expansion into the medical market An acquisition of the Colorado Operations is a first step towards continuing to build a diversified outsourced provider with leading technology solutions for our customers Facility has substantial capacity to continue to build out medical business

Review of Transaction Terms Transaction Type: Asset Purchase Equity Consideration: 1,000,000 Shares Subordinated Debt: Amount: $2,600,000 Term: Due 9/30/04 Interest Expense: Non-cash pay 10% first six months Compounded quarterly Increases 2% every six months Prepayment: No penalty for prepayment Registration Rights: HEI must use its reasonable best efforts make the shares become effective within 120 days after the closing. The shares would be freely tradable at that point.

Review of Transaction Terms Lease Assignment: HEI is providing a security deposit to the owner of the building equal to $1,500,000. HEI has an option to acquire the property and building. Severance Agreement: HEI assumes no employee contracts or severance costs. Contracts Assigned: Included in the purchase is the pipeline of business with their existing customers

Overview The Company conducts its business through two segments: Colorado operations and CIVCO operations Provides medical device outsourcing services and medical products. The outsourcing services group provides custom product design, development and manufacturing outsourcing services. The Company's development and manufacturing outsourcing services generally involve complex high-end devic Advanced Medical Products Colorado Operations Customers GE Medical Systems Johnson & Johnson Hitachi Gen-Probe Philips Others Competitors Plexus Corporation MedSource KMC Systems Pemstar Nova Biomedical UMM Electronics Sanmina UTI Corporation Sparton Corporation Analogic Corporation MKS Instruments Microtek Medical GE Diagnostic

HEI, Inc. Advanced Medical Products Division Design, develop and manufacture medical products diagnostic therapeutic biotech software development medical connectivity Imaging system design, develop and manufacture power amplifiers design and develop custom software systems Colorado Operations RELA IPS Acquired Assets

Facilities RELA's operations are housed in the 104,000 square feet leased facility (expanding to 154,000 square feet) in Boulder, Colorado. This facility is registered with the FDA for contract medical device manufacturing. The Company has the capability to manufacture Class I, II and III medical devices RELA R&D Pilot Manufacturing Manufacturing Warehouse Machine Shop Subtotal RELA Administrative IPS Total Square Feet Function/Operation 26,000 2,900 15,000 10,440 2,000 56,340 28,000 19,660 104,000 Advanced Medical Products Facilities Allocation of Space within Boulder Facility

Partnerships and Alliances Partnerships and Alliances Teledyne Technologies Colorado MEDtech has an alliance with Teledyne's Advanced Manufacturing Technologies business unit to provide low-cost country and high-volume manufacturing services. Cerner The Cerner partnership benefits the Company in two areas. First, as one of three partners to develop software applications using Cerner's base technology (Millenium), the Company will be in a position to expand its software / V&V project base using Cerner's client list (numbering in the hundreds). Second, through a collaborative development arrangement, a premier software application for Link-iT technology should evolve which Cerner intends to market, distribute, and sell to Cerner clients and which the Company intends to market, distribute, and sell to its base of OEM medical device clients Sun Microsystems The connectivity relationship with Sun will enable development clients to visit Sun's iForce Ready Center in the San Francisco Bay area and view connectivity concepts at the facility of a premier networking systems provider. The iForce configuration demonstrates the utility and safe operation of patient room connected instruments configured through embedded JAVA-based at-instrument processing linked to an instrument server running Sun software Red-M The Company is an alliance partner with Red-M and as a result the Company offers Red-M's Bluetooth solutions to the medical device market Low-cost country software development alliance The Company's software development pipeline includes an active alliance that provides direct access to a software development team in Ensenada, Mexico

Medical Device Software Verification & Validation Services Produces software for devices in diagnostic, monitoring, and critical therapeutic functions Development capabilities include embedded, real- time software systems and workstation-based systems typical of large, in vitro diagnostic instruments, as well as expertise in development of major concern software intended for life support systems, such as ventilators and defibrillators Overview Customers Services RELA develops both real-time and embedded systems programming for medical software, and provides verification and validation and software engineering for clinical information systems Engineers integrate software in a broad range of electro-mechanical systems and distributed processing architectures Abbott Labs Baxter Boston Scientific Cerner Corp. Datascope Draeger Haemoscope Hill-Rom Hitachi Medical Nellcor Neuron Therapeutics Medtronic Physio-Control Primus Respironics Sun Microsystems TheraSense Varian

Medical Information Systems & Device Connectivity - Link-iT Working under an agreement with Cerner Corporation, RELA provides development services as well as its Link-iT technology to Cerner clients - users of Cerner Millennium health care information system software The Cerner Millennium platform of products is capable of retrieving and disseminating patient- specific clinical and financial data across an entire health care system Overview The Product Connects Cerner Millennium Products to in- hospital medical devices Creates a new product line for Cerner to sell utilizing Link-iT Adds safe, timely, local, redundant clinical and administrative assistance What Is Link-iT? Software, hardware, and service product Part of a connectivity solution for Legacy devices - - can be embedded in new products Opportunities for ongoing customization System development Ongoing revenue stream - software license & service Summary Connects Cerner Millennium Products with Cerner has large upside Provides sales support by Cerner personnel Provides net revenue even the first year Has high (44%) Margins in Year 2 and thereafter Cerner Healthcare Conference showed interest in excess of expectation with concomitant upside potential

Transaction Rationale The acquisition of the Colorado Operations represents an opportunity to add significantly to HEI's engineering and design capabilities Differentiation through technology and value added engineering and design solutions is needed to avoid a commodity-type business Leverage of added technical competencies will enhance our attractiveness for microelectronic assembly and for high density substrates Software Capabilities The software engineering team in Colorado can support the expansion of those services to HEI's existing customer base Technology Strategic Reasons

Transaction Rationale In past years, HEI has assembled components for use in Class III medical devices (Medtronic and Angeon.) There is presently no such assembly business in the company Addition of the quality systems and Class III capabilities will allow HEI to seek opportunities for microelectronic assembly in some programs where it presently cannot quality The Colorado Operations provide development services as well as its Link-iT technology to Cerner clients Cerner products have large upside potential with attractive margins The Colorado Operations is developing the Link-iT device which could benefit from HEI's telecom engineering and design capabilities Capable presence launched into a market we find attractive Medical diagnostic Particularly GEMS and Phillips Therapeutic equipment Multiple customers Pilot manufacturing The Colorado Operations operates a pilot manufacturing facility that could offer assembly for manufacturing that is not yet at a volume to warrant full scale, dedicated assembly resources Horizontal Expansion Strategic Reasons

Transaction Rationale The addition of approximately $10 million in engineering services revenue and close to $15 million in G.E. Medical Systems ("GEMS") business would significantly moderate our current concentration risks in three critical areas Market concentration Hearing Customer concentration Sonic Siemens Program concentration Sonic faceplates The addition of an additional, well facilitized, location offers the capability to establish a limited microelectronics assembly capability as a risk mitigation effort for catastrophic incidents This topic comes up increasingly where HEI might otherwise be qualified as a sole source on a program The addition of a significant employee base with diverse skills will provide access to a larger pool of human resources. Long-term there are more opportunities for successfully filling management and supervisory positions from within the company with a larger employee base particularly in technical areas We often face questions related to our present size and whether or not there is the critical mass that many of our customers. The additional revenue and size would help address this concern Risk Management Strategic Reasons

Transaction Rationale Accretive to earnings New business relationships Multiple leading medical companies in the Colorado Operations customer base GEMS Cerner Phillips Valuable ongoing business opportunities GEMS business SSM Spares and repair Eagle program Phillips Cerner Timely Opportunity

Transaction Rationale HEI shareholder liquidity should be enhanced due to the additional shares to be issued. These shares should by and large become held by institutions which can lead to greater interest in the company by institutions and research analysts Shareholder Liquidity

EX-99.1

                                                                    EXHIBIT 99.1

                                                                    NEWS RELEASE
[LOGO] HEI INC
6385 Old Shady Oak Road
Eden Prairie, Minnesota 55344 USA
952-443-2500

CONTACTS:                                                  FOR IMMEDIATE RELEASE
         Anthony J. Fant, CEO
         Steve E. Tondera, CFO


                HEI, INC. ACQUIRES MEDICAL DEVICE DEVELOPMENT AND
               MANUFACTURING BUSINESS FROM COLORADO MEDTECH, INC.


Minneapolis, MN. and Boulder, CO.- January 24, 2003 -- HEI, Inc. (Nasdaq: HEII)
and Colorado MEDtech, Inc. (Nasdaq: CMED) today jointly announced that HEI has
acquired the Colorado Operations of Colorado MEDtech in a transaction creating a
global medical component design and manufacturing outsource business.

HEI noted that integrating Colorado MEDtech's Colorado operations with HEI will
result in a business that will be a strong contributor to HEI's overall results.
HEI said the agreement is expected to enhance HEI's long-term earnings and
financial position.

In consideration for HEI stock and subordinated debt, HEI has acquired the
products, technology and facilities related to Colorado MEDtech's advanced
medical technology development and manufacturing business. The transaction does
not include Colorado MEDtech's Kalona, Iowa based CIVCO Medical Instrument
business unit, which provides medical imaging products and accessories to the
ultrasound market.

HEI estimates that the acquired business will have revenue somewhere between
$20-$25 million for calendar year 2003 and is projecting that it will be
accretive to earnings per share - impacting HEI's earnings per share in the
second quarter of its fiscal year 2003.

 "I am very pleased that an agreement has been reached with Colorado MEDtech,"
said Anthony Fant, CEO of HEI. "HEI and Colorado MEDtech's Boulder division
present an extraordinarily good fit from the standpoint of customer and
technology synergies. By combining these businesses we can achieve a strong
competitive status worldwide without overlaps. The company that will emerge will
be uniquely equipped to meet out customers needs in the 21st Century. HEI has
been involved in the design and production of microlectronics circuits and
products for the medical and hearing business for over 35 years. This
acquisition makes us one of world's leading medical component design and
manufacturing outsource businesses. This market remains stable and we believe
that this acquisition will position us for substantial revenue growth and
profits as the trend to outsourcing continues to gain momentum in the medical
technology market. The consolidation of the operations and the restructured
workforce will greatly reduce costs and will prove to be a springboard for
exciting new business opportunities. This






transaction provides a truly progressive move for both our businesses. We are
extremely excited by what we view as a tremendous opportunity for growth."


"This transaction is important because it should provide a smooth transition for
clients, who will be able to continue their important work with their project
teams," said Stephen K. Onody, President and CEO of Colorado MEDtech. "The
conclusion of this transaction is a part of Colorado MEDtech's continuing plan
to maximize shareholder value."

ThinkEquity Partners, LLC acted as financial advisor to HEI, Inc. Colorado
MEDtech was advised by Tri-Artisan, LLC.

ABOUT HEI, INC
HEI, Inc. specializes in the design and manufacture of high performance, ultra
miniature microelectronic devices and high-technology products incorporating
those devices. HEI contributes to its customers' competitiveness in the hearing,
medical, communications, wireless and contact smart cards, other RF
applications, and industrial markets through innovative design solutions and by
the application of state-of-the art materials, processes and manufacturing
capabilities.

ABOUT COLORADO MEDTECH, INC
Colorado MEDtech, Inc., through its CIVCO Medical Instruments Co., Inc.
subsidiary, is a full service developer and manufacturer of medical devices and
equipment for the ultrasound and minimally invasive OEM and end-user markets.

HEI'S FORWARD-LOOKING STATEMENTS:
Information in this news release, which is not historical, includes
forward-looking statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Statements contained in this
press release, including the growth of specific markets, improved
competitiveness or results and the estimated HEI revenue, cash flow and profits,
are forward looking statements. All of such forward-looking statements involve
risks and uncertainties including, without limitation, adverse business or
market conditions, the ability of HEI to secure and satisfy customers, the
availability and cost of materials from HEI's suppliers, adverse competitive
developments, change in or cancellation of customer requirements, and other
risks detailed from time to time in HEI's SEC filings.

COLORADO MEDTECH'S FORWARD-LOOKING STATEMENTS
The statements in this news release are not historical facts, including those
regarding strategic alternatives, are forward-looking statements that represent
management's beliefs and assumptions based on currently available information.
Forward-looking statements can be identified by the use of words such as
"believes," "intends," "estimates," "may," "will," "should," "anticipated,"
"expected" or comparable terminology or by discussions of strategy. Although the
Company believes that the expectations reflected in such forward-looking
statements are reasonable, it cannot assure that these expectations will prove
to be correct. Such statements involve risks and uncertainties including, but
not limited to, the risk that the Company may not be able to successfully
complete one or more transactions identified in its exploration of strategic
alternatives, the risk that the Company's existing level of orders may not be
indicative of the level or trend of future orders, the risk that the Company may
not successfully complete the work encompassed by current or future orders, the
risk that unforeseen technical or production difficulties may adversely impact
project timing and financial performance, the risk of an adverse result in
pending or potential litigation, the risks associated with regulation by the
Federal Food and Drug Administration including compliance with the Quality
System Regulation, the risk that acquired companies cannot be successfully
integrated with the Company's existing operations and the risk that a downturn
in general economic conditions or customer budgets may adversely affect research
and development and capital expenditure budgets of potential customers upon
which the Company is dependent. Should one or more of these risks materialize
(or the consequences of such a development worsen), or should the underlying
assumptions prove incorrect, actual results could differ materially from those
forecasted or expected. These factors are more fully described in the Company's
documents filed from time to time with the Securities and Exchange Commission.
The Company disclaims any intention or obligation to update publicly or revise
such statements whether as a result of new information, future events or
otherwise.

EX-99.2

                                                                    EXHIBIT 99.2

                                                                    NEWS RELEASE
[LOGO] HEI INC
6385 Old Shady Oak Road
Eden Prairie, Minnesota 55344 USA
952-443-2500

CONTACTS:                                                  FOR IMMEDIATE RELEASE
         Anthony J. Fant, CEO
         Steve E. Tondera, Jr., CFO


                       HEI UNVEILS NEW MEDICAL ACQUISITION

Minneapolis - January 28, 2003 -- HEI, Inc. (Nasdaq: HEII) has acquired the
Colorado Operations of Colorado MEDtech, Inc. (Nasdaq: CMED), adding a leading
medical equipment, design and manufacturing division to its existing
microelectronics design and manufacturing capabilities. The new division based
in Boulder, Colorado, specializes in medical technology outsourcing services,
including device and software development, medical device connectivity and
manufacturing system components for medical imaging.

In consideration for 1 million shares of HEI common stock, it acquired
approximately $7 million in assets at book value and excluding certain
adjustments, will recognize a gain in excess of $1 million in the current
quarter. The assets include: intellectual property, equipment, inventory and the
facilities of Colorado MEDtech's advanced medical technology development and
manufacturing business. HEI estimates this business will add revenue of between
$20-$25 million for calendar year 2003. In connection with the purchase HEI will
add key research and development staff as well as professionals in process
engineering, marketing, product management and assembly.

HEI anticipates the combination of the Colorado operations with its
Microelectronics and High Density Interconnect divisions to have a positive
impact on its overall financial results. The transaction roughly doubles the
size of the company with:

    o    Combined revenue of over $50 million for calendar year 2003.

    o    Expected accretive to earnings to the current quarter and forward.

    o    HEI will have approximately 250 employees in 3 locations within the
         U.S.

    o    Expected gain in the current quarter in excess of $1 million from this
         transaction.

"We view this acquisition as an important milestone in the execution of our
strategic plan to add discerning technology to our business. With this move we
are better positioned to leverage our capabilities and facilities in a new
market for both the design and manufacturing of complex components and
subsystems in the medical equipment market. The customers and business of this
new division balances nicely with our hearing, medical implantable, industrial
and telecom customers," said Anthony Fant, CEO of HEI.











CONFERENCE CALL:
HEI will host a conference call at 4:30 p.m. EST, Tuesday, January 28, 2003 to
discuss this transaction. This call is being webcast and can be accessed in the
investor's section of HEI's web site at www.heii.com. The call will be recorded
and be available after the call at this same location on the web page

THINKEQUITY PARTNERS, LLC ACTED AS FINANCIAL ADVISOR TO HEI, INC. FOR THIS
TRANSACTION.



- --------------------------------------------------------------------------------
ABOUT HEI
HEI, Inc. specializes in the design and manufacture of high performance,
ultraminiature microelectronic devices and high-technology products
incorporating those devices. HEI contributes to its customers' competitiveness
in the hearing, medical, communications, wireless, RF identification, and
industrial markets through innovative design solutions and by the application of
state-of-the art materials, processes and manufacturing capabilities. For more
information, visit www.heii.com.

                                                  
Corporate Headquarters                               6385 Old Shady Oak Road, Suite 280, Eden Prairie, MN 55344
Microelectronics Division                            PO Box 5000, 1495 Steiger Lake Lane, Victoria, MN 55386
Medical Device Development and Manufacturing         4801 North 63rd Street, Boulder, CO 80301
High Density Interconnect Division                   610 South Rockford Drive, Tempe, AZ 85281
RF Identification and Smart Card Division            1546 Lake Drive West, Chanhassen, MN 55317


- --------------------------------------------------------------------------------

FORWARD LOOKING INFORMATION
Information in this news release, which is not historical, includes
forward-looking statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. All of such forward-looking
statements involve risks and uncertainties including, without limitation,
adverse business or market conditions, the ability of HEI to secure and satisfy
customers, the availability and cost of materials from HEI's suppliers, adverse
competitive developments, change in or cancellation of customer requirements,
and other risks detailed from time to time in HEI's SEC filings.

EX-99.3

                                                                    EXHIBIT 99.3

                                                                    NEWS RELEASE
[LOGO] HEI INC
6385 Old Shady Oak Road
Eden Prairie, Minnesota 55344 USA
952-443-2500

CONTACTS:                                                  FOR IMMEDIATE RELEASE
         Anthony J. Fant, CEO
         Steve E. Tondera, Jr., CFO


       HEI, INC. ANNOUNCES ACQUISITION OF MEDICAL COMPANY CONFERENCE CALL

MINNEAPOLIS--January 28, 2003--HEI, Inc. (Nasdaq: HEII, www.heii.com) will hold
a conference call to discuss its acquisition of the Colorado operations of
Colorado MEDtech, Inc., (Nasdaq: CMED, www.cmed.com) on Tuesday, January 28, at
4:30 p.m. Eastern Time (3:30 p.m. Central Time). The acquisition includes the
RELA and IPS divisions of Colorado MEDtech, Inc.

This call is being webcast and can be accessed in the investors section of HEI's
website at www.heii.com. The call will be recorded and be available after the
call at this same location on the web page.

The webcast is also being distributed over CCBN's Investor Distribution Network
to both institutional and individual investors. Individual investors can listen
to the call through CCBN's individual investor center at
www.companyboardroom.com.


CONTACT INFORMATION:
For more information, please contact Steve E. Tondera, CFO, at 952-443-7053.

- --------------------------------------------------------------------------------
ABOUT HEI
HEI, Inc. specializes in the design and manufacture of high performance,
ultraminiature microelectronic devices and high-technology products
incorporating those devices. HEI contributes to its customers' competitiveness
in the hearing, medical, communications, wireless, RF identification, and
industrial markets through innovative design solutions and by the application of
state-of-the art materials, processes and manufacturing capabilities. For more
information, visit www.heii.com.

                                                    
Corporate Headquarters                                 6385 Old Shady Oak Road, Suite 280, Eden Prairie, MN 55344
Microelectronics Division                              PO Box 5000, 1495 Steiger Lake Lane, Victoria, MN 55386
Medical Device Development and Manufacturing           4801 North 63rd Street, Boulder, CO 80301
High Density Interconnect Division                     610 South Rockford Drive, Tempe, AZ 85281
RF Identification and Smart Card Division              1546 Lake Drive West, Chanhassen, MN 55317


- --------------------------------------------------------------------------------

EX-99.4

HEI, Inc.

EX-99.5

Exhibit 99.5

Forward Looking Statements

Information in this presentation, which is not historical, includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements contained in this presentation, including the growth of specific markets, improved competitiveness or results, future customer contracts or relationships and estimated revenue, cash flow and profits, are forward looking statements. All such forward looking statements involve risks and uncertainties including, without limitation, adverse business or market conditions, the ability of HEI to secure and satisfy customers, the availability and cost of materials from HEI’s suppliers, adverse competitive developments, change in or cancellation of customer requirements, and other risks detailed from time to time in HEI’s SEC filings.

HEI, Inc. Shareholders’ Meeting
Sales & Marketing Summary

A. Marketing Activity 9/02 – 2/03
1. Marketing Activity — Position HEI for Sales Growth

     a. Existing Markets

• Address markets that best fit HEI core capabilities

– Hearing, Medical Implantable & RFID:

o      Identified and qualified customer & program gaps

o      Qualified customer contacts

o      Focused sales efforts on customers with best potential ROI

– Broadband

o      Consolidated programs, new account development & sales on largest opportunities

– Won 8 New Major Accounts

     b. New Markets

• Work markets that can utilize HEI core capabilities

– Supercomputing, Medical Equipment & Aerospace

o      Quantified flex and assembly market values

o      Identified key prospects & technology requirements

o      Augmented and focused sales teams on key customers.

– Won 5 New Major Accounts

2. New Customers in Existing Markets

     a. Hearing

• Interton, GmbH

– CIC hearing module. Production order in place 11/02

• Phonak, AG

– Ultra-low cost BTE/CIC/ITE module platform

– Prototype and preproduction order won 1/03

• Cochlear

– Cochlear implant flex qualification PO received 12/02

     b. Medical Implantable/ Device

• Animus

– Insulin pump module. Qualification order won 1/03

• Very Large Pacemaker Company

– Plastic ball grid array chip-scale packages (PBGA-CSPs)

– Qualification order won 1/03.

     c. Broadband

• Velocium (TRW)

– High frequency MCM – 10GHz

     d. RFID

• International Paper

– Cosmetic shelves (reader), tags on make-up

– Development PO received, upside 5M TRx /yr

• Meade

– Anti-piracy CD/ DVD case labels

– Development PO received 10M tags / yr

3. Current Customers

     a. Microelectronics

•	Siemens Medical Systems
	– 11/02 contract for FY’03 in place
•	Sonic Innovations
–	12/02 concluded contract negotiations for hybrids and face plates in CY ‘03
–	New BTE products moving into production
•	DSP Factory
–	New low cost programs coming to HEI, increasing revenue potential from by 3 to 4 X
•	Triquint
–	3 separate programs in, or entering qualification. Volume forecast in Q4 onwards
•	Agere
–	Pick up in demand in Q2 ‘03.

     b. High Density Interconnect Division

• MSEI

– Good flex/assembly volumes

– Displayed competitor Diconex on new Flex programs

• Guidant

– Strong demand in Q1. Dropped in Q2. Expect pick up in Q3 onward

     c. Advanced Medical Division

• GE Medical Systems

– Secured contract for CY ‘03.

– Upside for 2 MRI product platforms & service estimated @ $12M

• CADX

– Digital mammography system

• J & J

– Ongoing contracts for; Oblation device, fluid delivery system & morcelator.

• Dupont

– DNA analyzer for Pathogens

• Many blue-chip medical software programs

C. The Challenge — 2/03
1. Strategic Planning & Execution
a. Revise marketing plan to integrate HEI Advanced Medical Division into overall marketing strategy
b. Include HEI AMD in overall HEI Marketing Communications Plan

2. Reorganize sales team
a. Focus on large key accounts

• Stand-alone Microelectronics / Flex / Advanced Medical Accounts

• Leverage synergies across accounts / divisions to sell up or down the food chain

b. Close these near term prospects:

Microelectronics / HDI

•     GE Medical Systems

–     CT Flex assemblies & Ultrasound Flex Assemblies

•     Philips Medical Systems

–     Filmless X-Ray modules.

•     # 2 Hearing Manufacturer

–     Outsource all ceramic hybrid assembly business

–     Contract WIP.

•     Large Japanese Telecom

–     Quoted 600K/yr MMICs

•     Global Aerospace Solutions Provider

–     JSF Antenna arrays.

–     Missile guidance arrays

•     Alcatel

–     ESA MMIC packages

Advanced Medical Division

•     # 1 Hospital Management Information Systems Provider

–     Linking Hospital Management System to Patient Care Hardware with HEI (AMD) developed hardware & software.

–     In contract negotiation. Alphas est. 5/03.

D. HEI Sales Team

Don DeCosse	–	Central Sales / Broadband & Aerospace
Mark Derwin	–	East Coast Sales / Medical Equipment & Devices
Mart Diana	–	RFID
Jeff Flammer	- -	Applications
Len Klun	- -	Hearing
Carl Livingston	- -	RFID / High Frequency
Kevin Ritter	- -	West Coast / Medical Implantable / Medical Device

GRAPHIC 8 c74553c74553az0000.gif GRAPHIC begin 644 c74553c74553az0000.gif M1TE&.#EA]`(<`G<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"P` M````]`(<`H8````1$1$``#,`,P``,S,S```S`#,S,P`S,S,B(B(S,V8S9C,S M9F9$1$15555F,P!F,S-F,V9F9@!F9C-F9F9W=W=F9IEFF69FF9F99@"99F:9 M9IF9F0"9F3.9F6:(B(B9F9F9FHJ:JKK*VNK["QLK.TM;:W MN+FZN[R]OK_`P<+#Q,7&Q\C)RLO,S<[/T-'2T]35UM?8V=K;W-W>W^#AXN/D MY>;GZ.GJZ^SM[N_P\?+S]/7V]_CY^OO\_?[_``,*'$BPH,&#"!,J7,BPH<.' M$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI,F3*%.J7,FRIO M8,.*'4NVK-FS:-.J73_DDPVZ>234$8IY9145FGEE5AF66&67';IY9=@ABGFF&26F>2/:*:I MYIILMNGFFW#&*>><=-9IYYUXYJGGGGSVZ>>?@`8JZ*"$%FKHH8@FJNBBC#;J MZ*.01BKII)16:NFEF&:JZ::<=NKIIZ"&*NJHI&*&`@HQG'IJJJJRNJJJJ,+J M:JRMRFIKK;B^FBNMNO;*ZZ^S!GNKK\+N6BRQPP*;[+'*&KOLL\Y&BZRJFVY` MP;789JOMMMQVZ^VWX(8K[KCDEFONN>BFJ^ZZV&Y*`0`(Q"OOO/36:^^]^.:K M[[[S0H!``_%"`+"_`A/<@,$%#WSPP`LD+#`""4.\L,0/1VSQ_\075XSQQAIW MK+#'%$L,\@,?``]E[]P`$UWM; MK;C@4C<^M<](WQSYXTB[*[,(++"`.0HU@U`S"R'@/$+F,)Q0L^DPA/`YYBQP M+H+.F.,<.@NCGXXSZJ/C''L+FW_.^.%<"XYWU]`K M'OWTTE=/_?769X_]]M9SK7WVRXN\^B< MYPX"SIK3SH+IN?/.`N_^*QT,7I%"V(,2<@UL7-L:"E>HPJU]C6]7>Z$,8TA#&-IP MAC>L(0YQ>#BM)>][W-,@#XS6M<=-K68QD!SGC*8S&(P.:3/SV:8JD(#6=4Y_ M^=-<"UKGP/_I+G.8,]T#/]<_`6JQ=`^\V0'UQ\#SM9&`0VL=T%#%-`P6,8@P M.-X'3^BUOPF.A'XSW!^MUL.NA6V0A_1;(@WYPT7Z49&-C&3S"F>U#HH0B!WL M7N!P0$3*U:S_@"=X'1S'"(,';LH"!_#?"6!W,_E]\8NK+*45PXC%T250=+;+ M'^9R=T`"CL`&,HB!#80I3!D,SQ"4N:\X3F_>4-SBQB;"$T`N" MU4BHS1**L)LEM,'7P.:U;);3:MK\&CK/24YUMM.<[@P;X?@&1.EQ4'J7W M/,>"^WD.!$K[Y.Q\MD2:I=%F4TP`+C%'`0@X@`+YBV4(0."`BD[``1%80$,I M4-&*0H`"$XC`147*@)`N(`(5Y:A((T"!^ZTN!C>PP0A($`.:CN"F,C`!U4ZU MLX-&D04>>*@#)G`MHA+5`](#`5%!FJVE,G6I3L66!J*G@:*"X*8>_\`6",0& M/;UEK81&TY8&MHFT;8T5F]M,*S3U"`.E%A6D5YM:]*161`\@0$D&:.G^<$G0 MHBVP!5,L0.UPA@(A(0`$L*N9!L9T.=YQ#J8CL``%+C!9"F!@LK\$&M!R1T#. MW15),E.""S#6 MI0R$Z;N,1``*C,""/9O=`T'0@"0A8&I(6ZR5`@`]NQJVH@$0$@5*J$BP*B\( M\A52`4!`3@WDET@#8,'5@CNVY`TR>NTEDO_2L&:TJ7D@`@>6$D0->CZ=I=%] M!#`CS@Y\6-=]<@-$*L``5,QB`!S`Q3"V;0!F3.,A'>!^H3L@3#%P)`28-P:8 M$V4+ULCAS_:8P%;SKI4&(+8@L,#(1J)`)=VYS>>]S\;W*R$(,CPD",AUN&NE M<-68.Z3J_50#+[92`W#+1%F6DKJ9JH`!@O9`PWX.:"W0K8LYP.<^^]G/&4@S M`"B@`3I=M@`$4"X2!#X)@P!3R0!]`X&@ MHSQ"=)+3A$'0I:`#G[_X`-F[Z#9T'[V#UP@:!$0]LU;#E("$&MMWL%4R45"``:0 MV3LQ4IK70SHLU"J`)<:Q`+5(FD#ANIG60](6R]L$06V-%`!:@QE\Q+TU)Z%H M7R0%`&(-:\`$$,#E(@V@I49[H"Q'`(,I'D""/E-TSVJ&@@`_X`4^T($/GAWR M'XA\Y#Y(@:!;5\";@4#C:IS:#1Y-)`2,P)@<)J#I7M=/=-O99S2?T@%0N`(" M)&F_7>W;"TOH`0$,20"QUN:KB12!XS)X<91#&J\?-S,/&`!)$+@?Y8P8U(8+ M*:^M`S8+0"PT&)#8$=`"4,WO9)4>Y#UY0[0`>,-OP@GLK=]QC_PS< M@&J]"W)B?1XD=1O-TU,2`.`PG237:HUQ0,A:-U]]XVUNP.Q#BG7U$H=<#1J- MS$(Z8@P*7J0)`+1PV%3;UU@P`=`/8*PTR]W,$KIQFOT<:#B;>Y"4[8.\XSWD MS=8!M87TR1:,;@0O;_S]'A@Z\1Z)`!^HVJ5M9L6VTHSRH/5=T*5T\;VM`-Y' MVB_BR,8U$7+-!@8>D@$(+,*IUQS)4LMC^53:9%P1? M\T&B9B0"$$&B@S-3-&Q-_ M2>)E^I='S+1Q.+,`QE4SJ*=HWE1"?>-;>Q,V:1,#$99BGG-0*&!Q'M8Z,!K=L)T=R.L!WJ7=L(8`T)'A8LA0#)Q`#)@!N1%)>Y[57IL,_E09^ M/<8S-B@D!['&A`Y0X0S0X1!E_:$ M`$`S-OA>7@4],"1[9Y-6$V`D"V!!7:@I%R```W0S#_1V2H@"R:8#)$=R)G=W MS+9\0:)X`J1O%IAC4V,#*F@D!G`!YR4[?-5/+N>)Z08"L3.(06*$0\0"F3A$ MVIA4Z&>C.3"P=8"875:#B%:8-WQ3 M37(3`_Z2``B0`/PX8+)H2II"`0@P/V#8>)E#AS[C<310?+E8?'JW`[X(`(P6 M2W'H.4A3?3/78Q20*BY8:;P4C^'F4B)`C8,F/#93-=Y#8:P79=;S58JC`0,P M)`.099U&)%#':Q.0:QM'?3@CD@#``C8X5:3(/%^3>7ESE%*85O_43R#@.6VV M=IKR/GP5`XH6.Y\SA@<@<@]I?,P&@D$R-&D$>'+80(1'7C\6;*.C.E_T9.Z% M8RP`>43B`'?V.#?#`\.9&>^5AZ)C-Q9(>#F``80'%;A)6EPVA`F6ZD#57 MTSQM5G'5544%5&?2UXXP,(;*MH&\F'<^H`*"UDJ0`WC;UC.2?$5E\R^::/\4Y%\E`/[.11F*;5),J40I?J()X#G!@+'A9&G=`P3ED M;,0S%18T"YB<4^.7HT88./ M!3A.+X2/T*1!2+0I32=+!/1V8!H#)/@`+L!L19I\7]EW/A,Z9`E>_XF'0U)> M(@`"%V`!%U`!G0JJGCI9%=``)&9X`1IXIB.4[G4!A:8!&`"K&N`!L[H!&B!V MJ_=U8,2[(`"3F/359.XVF* M,.1;>FHV&%0Y`_E>H4-]I7G_1#GDT,T1HIQK`P8GY;``<0`"\VN$1"-/P3FXM& M0-9'_R8-B@+`^;0]LP$SB20.X#,W`SW$29U<)IU,%'2WISN7-GX-,)P$Y*QO M631=E4(-%@0VZD*&I+JO93;5`S4]8#D$]*V@QR5KM$3]=&`W=CYU:`.I*B8- MBC/\RB12%CI>5X0TLS=@.C1=N[`W(P(R:5L;,$&?@Z&#)F1F5*>R6:84=D@' M"$-T0[Y_=$A=936\QT8A0"8L%SQ+.CMUZ*3?E3_'NR3^R@(8`+!S*3R^XY]! M][6O$W2W]3\ZAZ8U-U;Y4SJ]F6Y3@P,4IGGB"9Y+9Z.Q^[92.$G3)#@1J+@S M,[D`8``'@``$<``&@``@[&('L,(LW,(M/"2VTU9MI7$&//\S`%HFJ;;$DZ9?MSX&M/A7-->--"*)2` MX32M_@4]"25!^J-H_%0Z<2DDJND"$JF!,JO&:.P".-N&U]9/[&IR;SG/Z.C<5*39V;<@0X)J7@'E@#@ M272(N&WU.25`OTZ"``N@`&GJ7EFTQ^E'6!Z@M$=2==S53X M`61LT"7:6BQ7,W6:8%2C/,/%H::V?J08A;3;Q5T3FG`4`R0&.1#,`R0H`6A< M?":7?-!VI(+F.&V%J"=(-;B<8O9B`4_)`/*2N\-(G7AU``)@PG;KCT;-@O'S MRT72`*@S.PW4,Q0@T``0`!#.O-+C0+X M.7=F`S$%_S24#"\>`$8FN0!/Z90H^Y24/;?]E,*MQVCZPSE^&'2'63,C$'0' M,)U-W49`77,\,[%3I<&"9$C2`YX:2IGDU#R9A\%Z]-#<(Y=#4G4+S'$]6V&:H]141T!P M=$`#50%I2M56O<_'^J6HS;%OO9[A M93-S'0.S:-"93-%[U7+1G[-+5`\>O9QR'=WD(I\ M^)EZ$V8SYTB#/2-S\8JPN#F:-O/,$TY8#PJZ$PU*6B3,'R#515*Y!@J\^ZJK M@ED!\:.P6)X_2Z2X.!#103)6D!DD/6!V(.!"#C8]#C9OY>0\FES;L*6^KBB! MGTF+93HU*8UW+5WM3KYR$WI$OKMH3Q>.(0CA>Z2`'/D>]=WYH]C$GL6]Y[J`%`A\``AXP]QM`]T_Y`8CI/QO0U41RX3S' MV>Y>,]'LMX((4./:"&M:^S@,H%K#'=3QB1DG*0T*A2*TE-,YP M]'/'1J&33X;/YH$:_]('3IQ[$X?MB"KV3"3)"#1K%+$[Z^7GX\]'`M#$:B2` M;.N@N^X,37?"VO)V.IUI/ET1/(Y*LC7O:"3ISJM"%,'8#`.5J&!K4[N:(KG' M5LJ\O7_4S_7,5NT;CW*NV34\\%-8^O-'<\-'HN\+_*VFK3DK#W17$@"NLP'\ M6]UTG/.LPU!<)@"`4`$#`E,1`(`(,*`AP@(3<@+CR!+C&`/3`T.1R-G9P]/# M@M")V.!Q"8.JFHH9PW.I(4`*0!$4$]33*CX_/S_N,^[_YRD'BI MGRJ.B$`((U*+&"4VS0(0P`.*1Y(D-;KT#<2H@P`0L&BDB:+&3@$>>#9:8).&%1[!-&&-:O6K5R[>OT*-JS8L;\L'/B&XN:ABI98\?#`<@<\ M>>_DTO.1`A\BJD:_P1A'Z)LE&1@H"K@PB6I-P0$E027UCR0+F!LUGF3Q0>]! M!BPBU8PD6<0W"@4X"6!$2<-:1(M&3*I4DI+_3E-GCPT(.L].G4JUN_CCV[=E_ MW?,N--.F>@E\9$FN8]R@S.G`AACZ4`4DY(A$&OWC$'Z5D3*`)"%XP!M%$(1S M0FB6222BZ9#3?AB);*.$;AQ`)1N:;!@1L5$((C&A"@ MD0*-729)B"R,QJ$`_T,ZLF$G@C#F5ULZY09#@[/DYHHN8FXDU"$!"*51`ZGT MH($'(%``@@87:,!DJJJNRFJKKG+5G7C?C$,58S"HDPB,'"'"X5JKK3:?=S&8 M8&!,I]#V"@S)@@@"!`.NP,)%Q=J)"`'T:7"<2!,V])DC$8J0*$L6/#(9APF( MRA"(*(BG%+*N7$"1B:V\(@JU&@5``7^I."#)`;]5^6K``@],<,&I5F"`=VBM M9=$^.-1F;\05E0EB##:D>1`(KR2;R3Z.P!`G8"*$,RVU!0`(0K8'^7E1"P!V M&XYJ,5;@"`IUSBR8")7$-UPJ&\?0@[.S]%"#B47K2X%F$LMHU*=%C:I!)/^H M&DQUU59?C74UW7T#I922+&NEQ'9:5+,W]DU[P`<]T^:1)`)2%-E%-XN=B`#> MB("M1A.X/&(C@HI&60$S14A90IXUU+8C#W.LDZX`R`OT<"R`T(#*=LH(D-E4 ME8JNC2!D#7KHHH]N]08#^$5B`P@0U192E:P.>^RRSTX[[1`$9M/%!B3`>^\( M)/"/NQQGPI<#!_!^?`('&'#\[=^T<($!`S`O/?73'R#`\M=G7[V_?DMT?>\% M$+"\`Z"Y%AA&CE2`@+_C(^`!34_U#OR'`L&P4*/B)0:?!OX"_S]6$&\?"ZD2 M!7ZWD0`D8`*DHL_'9,.<:)6*2*2KH`4OB,'L<`/_-OQ`'']>X0I^`&@0`9H$ M(4`P.1:4`P300EP*48A"]>6//![X@*A`@$-1.>)G2WF/(YH#1.=8`(@QE!`0 M,:`!$'A@B*6RH7.<6$,@#O$;$0*!$('X`0W8$(6""E0C3N*R*@TQBS@4E!*= M@T8`820BB),$1&8S"%'=$#H\\)D^*$$2_`WB1JJC78W*>#>:>%".A(A!!@^) MR$0J\AI[PF,X^M.F3^2B8SUK5!MA(`*;\`4C5&F(&]/BG=CL[&>0,U'D=+$L MON`O,:!1GVC\-@C$E>1^YTM<0T!3H9+DJ3&#@A*@!#DH<"2F)B`"33A<\Y"6 M)682RXS!PU@`I@["YH&N_S'3Y)1X1AT&*B`T\99W5(F*18ISG.0L)W>ZL9"; M^.Q$N+"!B9IRQUK!H#X*RZ-'?.F-=<$&-BV8X3$MP9^.;&!+7B`Q_WM MK&TMB)!K'!@.,":S0OM3Y6(:<0(P.A`C>0(1-[^(46\U`IE\B]9#'3J)DJ#P M26!DZ#<=)1Z>S;.+A\-E9_HF*&*"9I<1VID;66#.H`IUJ$0MJE&/BM2D*G6I M3&VJ4Y\*U:A*=:I4K:I5KXK5K&IUJUSMJE>_"M:PBG6L9"VK6<^*UK2J=:UL M;:M;WPK7N,IUKG2MJUWOBM>\ZG6O?.VK7_\*V,`*=K"$+:QA#XO8Q"IVL8QM MK/]C'PO9R$IVLI2MK&4OB]G,:G:SG.VL9S\+VM"*=K2D+:UI3XO:U*IVM:QM MK6M?"]O8RG:V:^7$,&P;#-S^HA/,0$22="L,W@H!`+T`KE>,JPSD%C<1M&UN MUDB16^(.5[J^\.UT=PO=Y%+W2,R]K76GN]WNAD6\S2`O,,SKW/0*["#8K6YX MW[M<7BC7N]LU$GJ76]_O@G,8>YB-\+NE2YY[WOAZNX720\V+X?%$F)B6#C`&6ZQJCZ, M8`_'^+PL5C%X%XQ;&%O7Q-TU,')+#&0`X]C'OB5R?G?_7.,?!]BV$-8Q<77+ M7`F[>,K66/*,1RSD#=]8RYS<(6[X1LG&,O[A3*2.ZQF M.+-9QT(^\8QS+&,JZSD;5K;SE3N\Y=V:&=!=KG.A"RW>1/_YS$I&]:$KC]\MYEN^>/TT-%M-YSDE.\8GE3.I''UG59AZUBK.+:$T? M&L2REG2M;:UE(&M:^7(>HKNSK-#"8VJEW-XUQ[^=0,1K.BI0SF4L]" MU\K&-:8I#6M>!_K7W/:N@N4\;%3?5LO&1G:?!PW@5(^;W+$>LKJ]3%]J'_O6 MSXZW@K?=[7RG^]ME#C>Z[PWK_W;/>]77EC&S!0UO@?=[T?^6]ZQW_><@T[?7 M^LYW?BV][XQ?=^.7MG'"':YPD->[X1H/^\WC@"V=XJXE>\TPS.]'B+B[&95YQFELZV!F7 M^KKO#7)K`YK3F^9TM=F-\F<7^>1:-K>?EXYS50<]NC6'>K>]WYOG5"2SOP@FZPVQ\/^#12 M+/O<9_^UP8XO;\IU#WRO'M[3N/?O[X./_-VSV>G%K[#MDP_]JW+]O,N'1O.C MCWVGYES$U4<\V.W^<\0W>=K9+W\&M^_TY><=W`>G<]WS_GSSR]]JZ'_YH3FN MZ*RG&OW^GK__KZ9LU39R)^=S(F=T_X>`!I-K:$=^<'=_9E=P"2B!5<-A#,AH M]A:!(==]$\B!K%*!XM9?$I>![W9]'6B"VA%A!(=N]6=_ZL=SC'>",>B!OU>` M+2AIX/9P`BB#._@J1_9Q=>9D03B"^<>#1<@D[[=UYU9XA"9XO"5<&F&$42A] M4"B%52A55&B%6%87A45B>&96B&9XB&::C_AFO(AFWHAF\( MAW$HAW-(AW5HAW>(AWFHAWO(AWWHAW\(B($HB(-(B(5HB(>(B(FHB(O(B(WH MB(\(B9$HB9-(B95HB9>(B9FHB9O(B9WHB9\(BJ$HBJ-(BJ5HBJ>(BJFHBJLH M#;2';],0@C[8<27(BJ178-27%13G8>FWBR_7B[4H>[JX%:]XB_;WBS8(C*_W MBSMV746V<:SFC,[X=QYWB\6(C,GH>CEFC$\&="K7BSUVC2K'9>+(C<07?]AH M>N7XC=[(?>5HC"(&;5?7@NYHC>B8C3C(COFXC/`XCKC(B_DHCO;(>A?GBP#Y MCKYXC#9WD+A8C.N8?@*Y>N;VD'$V_W;(.&3UZ'TWQX(0:83Q=XX$_L6,_O@,YZA*=/=H35=RR%!_HO9J&-AVQW=_2WA[+E=N'XEPZ_FV$"0%^@,-2B> M%]2<;->*\)F=UR!A[]ELX5D-VUEL^UE>0F=[`ZI=3P>@ MM]>?[7F>TA&?YOF?$XJ@YZ>.7A=F?.>$0X=Q;^:`&8ESS8AW(0J$=_=E`9F$ M7I=N[#5IX*>B09B<>+=O(\JB:>>B-[I^P]=F(!JDHY9V\85G=]>B0+I^S[AJ MSB:C*>JD/^>B(:IW*SIU"EJE;I:C+WJE+&IW4:IV^#>F9*JCTS;_HC/ZI8;6 MI0IZ:3]JIMMYHE6*-7J'D&JJHE-J963FI:J`GFJ)(ZJTJ:J'R:J;4:JZ_JJJJJD7X*J7VZ MH[`JC:-*J;X*H:URJZ+:ISWZJ$F7JR.VJ[3FI(7*9$RJJ@\JK*!ZJT/ZI[#* MIBF(J[_JHT2*K+6:JP6JK:F*I[$JI]$ZKY6JK'FF:51WK5:JK6ZFJ,$JKIAZ MKPB)K]!:@3FWI;2:IDJ*I-F*J_6ZKZC*_Z_#*HWEZGWPEZT%FV7!.JO/):=D MVJL:.W6]&K+D.ITE:Z+KJK+AN:]W2K+LJK"*9Z[+"K&=IK(#RZS3VEZ#2K/# M"K(#&ZI!"ZW/:+)":W#"6J.LZK+CVK,(]K+M6K2;"JQ0.[6\^JRHBJY8F[.O M*K7%JJE7JW$XJ['A"H#YAV<9"W_8]F:6&J9#JH(K"K<$2Y'D%X[0E5U;*JM$ M:JZ9V^[/2*7PB M65;->IV+9*"D4_^Q!(.[E-=[716\QR5.NSLZPWN$M%N^J>@/=J M).IQ\@ELI:J<1*BS7`:A0JJ\X0B^*S>+U7F?W.>?%-I>VBFAW_>[P(:=!DJ^ M.[>]TXL5PRN=1QJ]%4I82Z:I--:_"\IVQCN1^JF_U1NAT(N<_>B_Z4NO,.J_ M">G`O16@#&I\[7N^["F@WG:]`JQS_[N^#4J@\7B%AVNO:5NPRPFD+9JT\DJC M_:J03BNX&Z&T)4IS>YNY@?NK-CJZB[>D+,S`(:N+1YO"G8NZ8LK`B&O#V2;$ M*ARCBQO#4]JV25RDVN:O=AJF7'JT*'S%);S%AMNF;RK#<3J[A&O%VB?_L=7: MM%#KM#H+LS,[MC';NZ0ZMG-EKM`79QD5[MD&ZJ/R[MFO\M=BKL.3[K]T* MQS";I8>LR#RKD:8JL-:9QB?,M$@;M8]LL3Q[J5Y;L>$*MA/;L##,KB+KR$_; MQT[\5"W;P!-KR(5\JBD\OEW+K_IZPVG,K?DYM8X[R2_6W7E6W11O*UQ2X9R++DMC-)9C&MX*[/X&\./R\A1AKJBBZ9(O7\V M7<0_S:2D=K%+3-4UO;%?+<501M)_%<>@9L':P,'7&[XLRU]K_15P;9_?>U;( M.V!VG;M<@=?2"Q9[319R[;R!+=B#+5EI[9V&;6/P#-A:`8[TZYP$VM?)E:!; M-K_BB=CE27W=JZ'60<63O;M/Z-FAC=E])\&/[7M:==D*W-;;`=1V;-H)&MG& M-]FJ?=AJK9REO<"L'?^HJ3V>!&R^%QK"'RS>CV)S5S'VXUMW2+*S4/:O#B&NIH%MR=!MM*IS= MW-W51%W.3DS9-@NG\,K%G9JV0#BW5VS=XBW&.?VCE)O("2UU6(S)1YW5S@PZ M8GNS0.RSS[K1;=RNJ]S1NBRO=\R%$;ZH!$ZJM'JNB;S0+AO.`'W$;=;AG3S' M%TVPWUK'ZOS,#TZH;)O'/_S1)SZNAVRJZ,RQ!*W1I8SA(BNU$#[C/A[5YZKB M"Y[*]$ROSMS+BTRXDSS6GLO./_WDR`SB(>ZO1I[*W%KB(9ZX;$OB69JD0JO_ MY=R=;(@LU+F\S.V-MA]ZS?4]OHN;M`P.C48.G0^M.\,Y$1NR8T^SP\]TF2KU3_>G3L.T1Q.S6!KX1*MV-$-TB6. MYPS^S`B]XO5RR.>ZYSN;BC. MS8'.V[_EA$*]SOFZWO;:MNR-W/H=MX'\WFH'[05NN9U[MZ!<[>^:U++(N0TX MQ;*,;4OZW24>U3M=S0JUN8N?LU\I7UKD>5LTV!MLM0^W9?;N,X6HT#7 M[?'*[?E=HY.+U0Z+W8Z*Q.J=2,%.P?:)6`A/?ZF"__"+;5^V2U9^765T/8.& M1?&\F[S!#O%%DO&$#?(A+_*_:Y:Z+378?U[X%.L&Y[7SO>8#,"?$!W7C9 MZ]CPAMC+76&L>V817-D;W(K9R?#[*<(-*JH>_/+0F:-$^_+Z/O##7$'_#K\T MCY_#W9VX_=OS.=O`G?"P2-Q5W_.0W:QNNO/%/9]R/?3#6/0@G/5:W[WNBL%A MG\Q,?V"(5*2!A]]ERM0!#KB_G/=8G(387,9/K[:QB[:0/LM8>]Y+#/"?B]Q( M3=W1+O7:K-[N!]637]Z/3\35CL,T7-W2VM1MKKVW7KF##[JK2^`J7=S)Q.KGDH[CK^[H MT^?K$B[=2F[$;T[1JISDL][\&QVU"\W3/;[[SI_>_=[#67[CQWOW-PW]S&WCH+_&:)RBE2;_K&O,ZFKHQ`\(`$*"`(2$@X6" M0HB+A8B&BHF+DY*.B8:4F):8CY*,CXR;H9"7DZ.GIZ6;HJ"FJ:*PA[&9J:^- MLY:HKI6:LI>1JXJVP;V=O,*AG[2Z[Y9S?J*R?N>#5K/6U][ZSY_F*2>M&3YM`<;[(@5,(+)FR M0=G_E$VSUW`@-UT+)T8,I@L@M8\0_PT;.5&@*9`4R76\V,D6PY,)889,B'"F MRI0@2]*L*%-DHY8Z;XZZ5M.>RFKODBI=RM0CJ6U'54DE%:\F0JA8FU4U!JD5 MPZ?$9C[EFG&;UJ'R//TRRW$7V[69WE*<2I;8U+)TX:[=VU5M3[ZK).ZMZT\O MX*&@#(;%QS8N)<&``V?UV-*96,*]H+T\AEEJ8LW"Y'IRECGR3[>@KQJ^^K"I MZ]>P8\N>39ORM=JX<^O>S;MWS].^@Z^[+;RX\>/LB`=7CKRY\^?0DVJ.3KVZ M==W0F%^/K7V[]^\GFR\$3[Z\^?/HTZM?S[Z]^_?PX\N?_T^_OOW[^//KW\^_ MO___``8HX(`$XC=:ZHUV%"*8S'H:.+:C:6X?0 M=M:##(IGU'C#H8@.A[.5J"!W+N8&%T`)OL-B@>6IN**&,:K3XU+RB'@;BAL^ M"*2//TXHG7(Z+OG2A.+@UB2%22X'#U-3RK1;C%FRM\]CKW6)8XI?V14D6J%5 M:%56@S&FE6%`I2DA3#.V)EEF*9'5V4.#D::EFP>VY5E58*E5$:"-#?IG0VF> MMN$QAQE#VHC1Z&EFGN%0%=:DD?E46:($@6FD\&TG+D[(Y(8:3K\%^)&VT\TB&F+4!;>6IKSOQ$V*AD0CUZ#2Z:@NNUYA^>?:YO'[K4MKECBRULR3+C#2V'*]]+TI_ M)\LLV4K_VXCPA]EB>V>$7QUFCM\7)R:6+];^Y!F2JD>Z"[W.(9DK50-7R,+W1'`[_&N2"CUDH2$A MB4>V0]^"0+@EMAVN=)AC1L\,U\(B&A&&@[K>638E(8JY3E&M__O2K"KWESKU MZ8HH,9W.\E6T%"(++[FK%!1-([<3MBIB;2,B"M\FNN"%\(APC*/C`G8K=+7K M=S2[54SR)<4?:J1O*L.QRV$6AO"IE MC).C)C>9G#JV#%A.%*02S6:6VYF+1W@#)%A$6;R&I8M--L-8S,C&M;;4XI7Z M.I7=?/@M#B$E07\S6EZ4B7:FAFBZ.$*7[(< MER(?&43UU9*06?M8V^PUMR@993.:"I+\C,E.!D).<[*#%.4FECQ)JJ(5UHL0 M:JA'N4DU+W3\'%(;,?//NKAK=FWBG/1CV'A/[*VF0\(3WT)E-4_A*10?[O6K8`VK6,=*UK*:]:QH3:M:U\K6MKKUK7"-JUSG2M>ZVO6N>,VK7O?* MU[[Z]:^`#:Q@!TO8PAKVL(A-K&(7R]C&.O:QD(VL9"=+V GRAPHIC 9 c74553c74553z0001.gif GRAPHIC begin 644 c74553c74553z0001.gif M1TE&.#EA]`(<`G<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"P` M````]`(<`H0```"4GK'___\!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,! M`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,! M`@,!`@,!`@,!`@,!`@,"_Y2/JHJ:JKK*VNKZ"ALK.TM;:WN+FZN[R]OK^PL<+#Q, M7&Q\C)RLO,S M/PMNT#X&#R^OOY^0ST/O#>"!=/P*&O2G@V!`@?44&GQ(+I\Y<-KZ06M7L2&^ M;O_?&I[+9E$`0G_;0(HLZ6[BR70@%9IL"=,AQ)F.4F:DR#*FQYTX>_+,23"H MM(HD96H\6N^G1HY!5^+\.=0ES:F0-CY%NA*IR9U9NY[$RM1GUZ(,Q[+4"O3C MT(%IL^KD2C6N-9D2T;7M:+%M7K91Q89E0':IR*4O79;D2_CO6+F,YPK$>%%H M7[5I%>]%ZU>O`J-?$4_>[/`PY@7?SC8^3<@J8J^6/=\U:O>S6=F@'QN63#HT M9*QY(W-R/:LP37[.=79PB6*''1S?835GM0-Y.I8-=O36X]CRE^0)-[M2W M^.^^O=,K+3F]^&@90=B&***J[( M8HLNO@ACC#+.2&.--MZ(8XXZ[LACCS[^"&2+)P1)9)%&'HEDDDHNR6233CX) M991+#BEEE59>B6666F[)99=>?BFD"6".26:99IZ)9IIJKEGCAFZ^"6><??OX):*""#DIHH88>BFBBBB[*:*../@III)).2FFEEJ(` M``0@&I`BIQ\.:4&'8B+PJ::9ZE"J`J)2(.(!)'KJ80.G=K`JJ2;:&BL#MNJNN>H*+`;#_T:P*:@;K"IJL@^DBJNTG@9KK1K'.@`LK\*2 MVD.V((C;*PGDRJHKN*&ZZNVOZJ9[K@32MNLJI^^6BZJ]]58P:[_TIALLJ[_& M*_"X^Q(L@+7#9HOPM'(TRZVJ[W8;K@H-)VQN!O/>.\&_&.O+L;L7HXLOR!\3 M/+*S'YLL[[XKL^QNP"U+'$+*)*^,\LTPAZQQ'*U&'#/(%/>Z[+'17IMPO_5" MN_"VMB[M;='0PIIIU%;/:^S3[!:;Z[);;RULUTD/O#'20M-<,M9*2^VUR?22 MFRK751_-KLM)MRLUOJ7.33;1US*\,*[@,GVUX&C3S+?A&!-.]K;N_I8Y^-L]ZF MWUY[[J,K7?+LO+\,=MA.`S^Q[:[_7K;;=0-\,O*SORY[\ZOC;G?4M!/?>]#. MFR[[]KE/OOC49QM->_2IZ^ZP]JRO#_OUY[_N/OMD#)^]X^LG.SWP_WI_==4\ M?PLUL:E/:)_R6.OT1S;Q80^!"]Q?\(Q7O*!=CEK4XYT!J^C7@7E MYS'D49!Y$H0?`$MG/P;*#W[<$^`'/,,&1I")'03BSI:H00O_3NZ"EG/@TJJG M177)T&LA;%_'2&A"TEUNB``,(ALMU\0#RM%Z,V19#;>H1@9V*X=VU,,/=P>O M*"IQC!)D&!+AR,$-!I)C=R1>&V%H1"NB[9%5O"/^OL?'WL&MD!B4(>Y.^$1% MFO%BEQ1C'Q&824IBCY".%%G[0`DS<5&RD>R#)2R_F$)5TN&/G$1<\?B7/R]Z M\I-SA%TB8V@\';XPC%-,'B9K*6OIC&.GOT[XMVLUK=8A>YQ M(PS1\PYJ-,D1+9][G)M#,\=*%YK1OK'TGR:MZ-=&6L>/TJ]Q.E7I3`U*4XBJPF8< M("J&C)H%I+)`J7)AZ@6<.B&H4D&J*AL05<\(J*M"0:LCX*I!=DJEMN7)JTO@ M:`[(>JFTJG6M;&VK6]\*U[C*=:YTK:M=[XK7O.IUKWSMJU__NE"8CDBB8NV8 M#\VZ+M\Q]*7!HRA0D48WP$8H;X+4WS`U53!:N6]_8:,F#;>'5LDVM;-F#"45 MUPFTHLIS8J2M8BN5*%H&^2]V4X0F/V4*N=3FEK':XQH59ZO-TNZL:UR,[8&` M"]R@VG":H/^%+&:/YTXX+A>7P77I-5-KW`0A-X6OS:-+`3G#;.JL?H.CKB1+ M.=[L&FAUF>QN=),HR4D*%[7@@UX1X7O:T*KWJ[3E[GQ9B4T>?A.[]+6O?UV[ MR?TB*)N/;*TYUR;@=\;WM`A=[2GMF&`%$VA3_#.8PBWG,9"ZSF<^,YC0G MJF%2)>60U3Q9'KMR!E=],YP9\[F(V3G"3[WS41][LX9&#K+.`RG_3V5J-H36 M='E^?E">F6=+LUGP?SIG53TT9=$;8:G>[$=#QWZ.L+\=.G MU-K;HE^:9Z`Z,7,X37:@>FUMM6([VY?:-KEOBWO]WL M;K>[WPWO>,M[WO2NM[VW^C0Y=P[6*=;WP&I`/W]'U)_*0AEB?WSO+227EN2] M+('Y93`BU_:Y5SQU3L?+5&\G?`4+K_AR'9[>S&I6XO,->8&Q>G&+IWSC1@C= M`*?9T\(]--&5>ZA"#VVXK"W/Q('%>0$S_TA&T(D0;RN]K7392\?@CABYIR,N MRXO0W)>C5WRT)+&Q$=S?V5X=YN(E(#'Q^'7IA3V>'X%/WP'$ M&MEU=G)4V#QUN`(=Y\*I0[-\3DL>IDE-]F&6C7^W<#,U?>FQ^Y*]7R^]A"V/ M8M"_\^^9]^PY-W].9+)]]`#')Z"+WG<.W[S$)B:Q=3MJ:'QF,.:>/I[:`.K\ MQ;;8V0IK-D$;)WSJB]2DO->3Z+LOI^^#'T[B'_^&#F[^]*M__>QOO_O?#__X MRU^[\X_QB2?(YO^Q%;ZH`O]WJ)Q*6?B58C]6?OY75AD'.L-%,?M7@'3B/[7G M<2^FQ,44D&H,'&D4&*%4943 M/I%%/C:U2LJ'A#&U?#VU?<9773]7;?=$:'47A,!77@DD:8KF+P%T2V+3/;&S M8I+6@!D2=!B7A(87/FH'=R7'>I\GAT281EGG2[GG@\ZEAEMG:;>C0W582VVO5<0\7=5OWB*?_ATCM M=82J]UNXQXBJ2$?X=7>"MVH#1'BPR'=OV$VP5XN7M39Y=XNHYS:X5XD_=5?; M=7&AB(JT&%_?4H83=GNA5RZLB(@OA((FU`XS1"$5O]8"N95JIMXI8IXYWJ'7J>(L=%GO0^(B5%G:)R(?G%8NC2(S6 MJ(]J1(_^2$00.#[F&(\PUWKS&(T)*5=+V$*"MG2W$GU5"'0;U6$V5U,-=3YT M@Y$J1CC9IV)72%,8^4`C5H4CN48AYF`IA9('E45:!U(C^9)#R(4V"7P:V3\. M]6RO(FT^]9!M((#\T8:Q590P@%X!F5CF:#5_"4^C"6<.5A*7A6S')_`J-1,NB6(M!:!WB./8:`%,&@SG0B#2_4$(SAR++A(Z"*3PF1>*/A7A28#2@64 M8=B4Z3,RO5:6!,95;09I2NA>^#B4>:6#Y721MH.23@>)VF>&,+E'!$=S:EB$ M8V>$'I=;,JDYU,:$_E=23R$*)N[F(14AY$?6%.M6:-B2$)%5,,[>9 M6<6;.`2=#/F#K]27-[B2Y12':)>=O-AS'0F):92=>32QR:;JQ1R>.F-VO^$F'PIBQL5CG5';.2$/QL#7\;8CJ]'BL+XB]*XF^;C MGQZT-W?9GV)T?7AGBSP9H<1XGPRV1)WFE^"UA\$8 M=P/V3,&(35'W>+%T2?:H3IFV?_")>=Q8=?NF:]PEG_GIH;)8CSA:H`"J0H&9 MD'JWD/=8F8S:EFL0' M=+S)?2H9E1V*:`65IIU2D6C(D4R(DR[V:)*S=%J3FCIGD8,%DBKE>S,'DR>Y M6%;XDGPF5"DE.-SWENR6E'9)`]DH@9C"!E2%,'7V=(^Z` M,Z@06G!N]JW/4FJ@*B"7.JFJEG^(&JORB(.HFC'O&I8(9I"%^7"4"C3GTH&0 MBH.$V:C=-6/FV@SHRJ_A!7&XRG@%FZX6,Z\-"Y!NF3)`%IBGMJ^H>HH^1(', M")<.4IITJ)LW1T\[J(5\ZEW&27?K='_5"84X(X6]B5L7:8NM(Z>#MU.O^;%K M)X4L"ZAM^;(0F7,*2(^"&CB3V).5!E`_J9N,IXA/_TAY/,ES%"*>*2I[#JFC MJ.=169BD&-=ZY_FD6-N>3:B@&&9V?MFDIV1L7,N0-BJBA(AV9@M)1KNU-*NB M2^JB[WEHX+F+@EB>D&E5]XF0#2I?$0E!@_9)8%5J%V:/80JE.T=LH31INL69 M+G2A`9F%[TBC>AI[!+FFD#9'UXF@IL>`C;>ETG-,`DL,,/JWCH2BNZ>A9TIA MLR2D#8DZ1".,]J'P:M(7?MRV2.(VEN)W'NE86NW5HJ* M@;NEXWN/'IFYI!B\(?J[1\6?195FAC%J#A)DOW;4HI&;8WY.<%G:#"; M=`WLKJ)UJZARM7[0;*U@5*9K)WO)`^;$!S:<"C%<9#3L=M%UPSZ,Q5FLQ5O,Q5WLQ5\,QF$L MQF-,QF5LQF>,QFFLQFO,QFWLQF\,QW$LQW-,QW5LQW>,QWFLQS^@F39[K7K# M<#*\QTE`MG]IKU[:L(.\!_Y6R(:9R/GUR(I\!^CW::VXOXJ5EW,7>KO(NP\* M;8+_+,D<&&ZL)(H=2;_)&(F,.X55FZ6A7*EP\W:[.WLG>5T%FKH1Z:^N/`<- M=L(6=HV=VLOD"\3CJLO&RIS>5;K>A(U&Y+T*B:C%7*G)1)OIA,KK:[R=Y\S0 M[#,0.6U>>+^?3,)Z67PG]9/0V]\P:K6?V>8@?5+&?BE6@7"G)&P,Z3*H5G5GK>IGTI:DL_98&A,.B MN=$4;;!8UK$WM(6*S0[C7/`_YF'(?N8UM1%A^JY M3LNST73`1ZJEJIMOF#R;6.B%>KJ&$#V="IFW<;NUT+6,4>:`NP2_JO6?:A43FB=QO6NN>X$UHX"=O7@MM+ M\YN+/%3!H6E)UBS+NA;8CAB:C=N7_.G-[65FEQUHO=A)%QK4K22.G.N.N9?1 MCJW:MHE:D^BVS*6\K6O5Y)BA$3J-I@J[-8W3L0M>;TVYBBO-!N9ZLYRPT^N- M:PC"SXB\5WV\T3NWONV@$*U\`&4#VG)KS` M1JQG&8G"]/_)?,:IWI69DV4HW]S]4R=\H^H66BLLE(J7 MJO>:TB.XBFNXBN.;@*^5`#(XKM$X3EFJ3'^!A'KR`=NXPKW>PK8A?W- MR:?9U$SMFV`8B+NUXV/@=[9LSF2-W9[[>6W+X4DNQ'Y[S8Q-WZ0[N8U+Y4J. MVDO]G_'KM^J+B7/9Y5^`0IY\Y;;U11,P$V>U,K%P63ZIG`> MYPK7YZ?[Y\/`YX'^,"!.Z(>.Z(FNZ(O.Z(WNZ(_.L18SZ)#N`XULTPQ+Z6!@ MZ3H>JIG_[@0Y/48Y:^=D"&)XVG2T-;,EB>2>CF_06]6EW(>"N4_Q67FLOE5Q M<\R/S8_,!6!@;J"VW@2WI-8UJHLV"D^XA'B;#NQ(H-<%";^H_.RD;([5M>R? MWK+^C:="'7`$]-.W`M75_@J3#NZV.NZL(.[EGE3GCN[KSN[M[N[O#N_Q+N_S M3N_U;N_WCN_YKN_[SN_VK*\Y2]"&_N#4>H+PVN\+G=$%SZD*"[$'WV_+RMN1 M+-(,3[$.;RK:FIL.S*B`NUM,^[)%]VJL^7,[]]5&GN\83_!DKJ-[_>KS6:_7 MW3Q1FN9_C>ZU6L@MQGEN/>9L/MW&;7HTW^X8F^7U>U^?M?/!_[R=#@9&/Q^; M%C])O#;T)(JZU)VOEDF+*^J\]YYKF+VA@QT_+NK^_W?P_X@2_X@T_XA6_XAX_X MB:_X?R+P`WC1;];W@4Y6$WO(G+[X*SCQ%D[CES\M/:YV6TUIB4W.9:J1`@R% MN/G=XMSTG.^[FAB'VPOK//_F8YMVS%8GNG:OO%<5ZZTE7P[H2$H M+-*.PUDR2?$QH,351^H"*D^CIA;;]7[!8?&8K)G"KN7:]L9^N=6\!UQN/C[/ MO^K837?XXP(%!PD+ARP0__),4("N$CNHH")7*%D>*2M[,)XN13BE+E-80"$U MIT@U&C-!12(G48E603!E>S(2&4N#2'-E%3]X0SP_TUI=655MAU&8-=,F'8MR M+6\-K[&SM;>=4A^K-HO!%Z+W]G!#RS_-THWSB-6CQ.>AC>/KYB5;[XGI:1O' MY8-VCLJZ:<+_>&02E6Y4:$V,ZJT-Z>7S8`^ MESI])\HA2*M7L6;UX$ZFSI6LEI(;51)?6)=CS;[*Y]7GS9>QAH9#FO/I7+,$ M$0X-)I1GWZ1U6^*C^S*LW)K)]&Y$K)5Q8\>%YFJDAV[B3H@(E98-+-+RIK]D MX_(U7*>PY="@)8[VK/FR9*FO>7X>_;9SP*24R6Y1'0KG8]^_@6.AVK,ILG*I M.&WPEA!1\V.G=G6*-AT2KE4`;0V/SCR[6.NOJ$K[U;SZ\?(7>_T!_U_MEMIE MJLR3E_]>N2]E%=$#;"]_^HF%@Y$+3L`!"1S0O@+%R"L;0`3;AL%#`D10P@DI ME'"L"K]0$)L'7=*&PQTNQ%#$$4F\*L0206S0D`]17*/#%F&,448P#IQQB:86 M4R-'&T&,D,AC%+**:FLTLHKLS3SS\! M#53000DMU-!#$4U4T449C5'#1B&-5-(2^IB/-F`FS51307VD2ZI-00T54>?F MZ$O44U$%U%(G-,,.+^E2C576+$G=BASZZO^A;ZI9>>WUR4Y5C$PO85GTU=AC M,?0C+V+]X@O99Z%5(O&8U]Y[9:P5WWWY[=???P$.6."!"2[8X(,13ECAA1ENV.&' M(8Y8XHDIKMCBBS'.6..-.>[8XX]!#EGDD4DNV>2344Y9Y959;GGC'5V.F2E7 MT6"BV!]NKCEGG.M=RS]KF>+9!J!U0*ZKH,7"F545%;'N5DI)@'E'L+I8%XF# MB":CJB4OO'E;&G7D8]=2+L4(C=X*:D/L<=='6IIC;&=@VITY MBSR9I2S8G69$]_IX?QV="(N*7G==H6=UPCSQ*4YFI``4[MA,'`E-3%0NFQ8#1RZ``:6.-[;%-)9ZB&WY2PY;_ M=4*!;I$+]W9#$0SVS'JU:6'W2*-`S_!C=8X"QFQ0)[G(U&@V;4O,U@Y4_T3. MF1`P\^N?-.X7D2"&*#-_LXNI%J'!:G7+>J0R8D-^@D6]^2Z%F8M)@")HFL+T M8WS::V+9G#<3)2YN@UDDEKF>H4+`7*Y%@4.*'$43FU*]$39X82)KQ@B7.48. M+4QCT5W08T/999$E7Z1)&E?#F4<-JW8[V=]F$LD%UYSP-$L$(E1,\T15$A)S M-"PE).MH2&Z!KC5-7*/F\%?#2R;P4T-TXV0BN!L"OM*4MES&7>1W1!D(TS:4 M*2$E92FY,@*S+9&K%K7TL4))6M!6SB1E#'591O'$L)>KI*89>6G,-Q[EC!"D M5@?5F1LC4<-X]+N>0ISSG]3E!(KYB<]W>K@/@/]*8CX+@6)_%&,TO'%G%^I[ M'D#1.*YQ0I1JR3D/+;*#T,PI-*/J`&!TOF.^<25-E`=-HC=DM?`1M8P0Z6L(6M$UC:.KLETM*PC7T7"ZTP M,WXFUK&5[2-DX39(:5J6L^':Y7M<@SQN^JRSI;61!V\#0F[2S+2MA1'Q[D-' M9ZW5M;4%"6S/5\@0VI;"M]I"7!518];>#I="\`@I0F=AM,70EKC-=>YSH1M= MZ4Z7NM6U[G6QFUWM;I>[W?7N=\$;7O&.E[SE->]YT9M>]:Z7O>UU[WOA&U_Y MSI>^];7O??&;7_WNE[_]]>]_`1Q@`0^8P`4V\($1G&`%+YC!#7;P@R%"P``.S\_ ` end GRAPHIC 10 c74553c74553z0002.gif GRAPHIC begin 644 c74553c74553z0002.gif M1TE&.#EA]`(<`G<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"P` M````]`(<`H0```"4GK'___\!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,! M`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,! M`@,!`@,!`@,!`@,!`@,"_Y2/JHJ:JKK*VNKZ"ALK.TM;:WN+FZN[R]OK^PL<+#Q, M7&Q\C)RLO,S<[/P,'4T50$V=4TU1K8V-P5UB+1U>#"Y`7N,]X8V>;1ZB+0X? M;-Z.A+Y^D."?`:`+>_0:"$R1;Y]"6>\6%)3P$`7!@PXBCDBX,*.K M;?\(M@&T)I"C`8\C[WD,2;&A0W+K1)83.4]ER9K#K M5[16V6(56[:H1:UT-[DEVS'H4ZY/V\Z%F^^H6K)N3>J5BK&N8DDXY3K-.W5P M0KF0X58<'/:P6,UWL7'^NS@TI'Y]`3OVFY0FZ=(/)F[&W/ET7-9W1=NN9-;T M8]61=Y=[>Q9V\+2R.6H&+KGXN^.I;SM'Q+,I3^-=]UK76SWIR:K4G49WV;TW MR/'8FS\_7VL[^O7L:=1L#S_^"M+RZ]L7D?N^_OT!E_+__P]@@`(.2&"!!AZ( M8((*+LA@@PX^"&&$$DY((1X`7(AAAAINR&&''GX(8H@BCDABB2:>B&***J[( M8HLNO@ACC#+.2&.--MZ(8XXZGGC"CC[^"&200@Y)9)%&'HEDDDHN662/3#X) M99123DEEE59>B666/)J@99=>?@EFF&*.26:9+U:(9IIJKLEFFVZ^"6><??OX):*""#DIHH88>BFBBBB[*:*../@III)).2FFEEEZ* M::::;LIIIYY^"FJHHHY*:JFFGHIJJJK.```$'CIP(:L8DM#J`K&"H*$!MZYJ MX*RN)E!K`\&^,*P+Q6YPK*Z\__::X:_*.@M#LBM(BX&TU"Y['XRZPX[;KKK<(^)HLN0?8:VZSX-X[;[K8RI?KMOJJ M6RNW!?.[[[D'([QPP@TS7/"M[#HL\;P$,_QLOPOGBW#"\'H\\;_VF0MKQQF' M/#'*)A-<,0,JGPQSS!UO;*O%(`.;\CS/C+/,X@*=<]'JUBRTNT1[ M7'3+03\;,M0VZ]PS@\.B^[5&PI.N+8D+ZYPP!H; MC#CEX?]>?OC/?F]>@>:^VV MWXY[[KKOSGOOOL-'<@A.2^"O"J+_'N'Q%_!,K?+((E^G\YUOV_6TT$^H+=)D M1WQPXX=/?G*L^KX[>+F59Z[UT9%OC_G'USO(O?KMMTRSUO7C?;;-]]N_/[SX MO_\@NE&->_D#&];H9;?OY:UM+(M9RH('P`0)\&4,=!B_\@>T>EEP;%1+6M0B M:#6]45!J)*S?!MG%M1.6L&XJPQL()2B^&%YNM7`S\& MN05*[X6*&B(13V?$(XXNB4K\7/&:",4H2G&*5*RB%:^(Q2S_:G&+7.RB%[_H MI-01;V@4R%?CQA?#'CR12YY+UQJ5UC<+,!&,63#@])XV@0HR#6XZF./R\N@U MXHE`$G0\G!E=G2G&$;94`=.<"[@31L M\`1F/,-74)B54X$/Z^C>S#G->GZT;V^,*"`_B3_Q43.F&AP;`W^J/9K]KX0Z MI>DZ5ZB_DWITH"1-:=QVFLV83NV##KW@3D]8U*;:5`-!1-_W"'@Q(/K+C`3, MH;@4Q\F5>2^'(C5?Y7*Y41X*DX>3*^O.#'?+@9$1G[GDF%O#"CY0[A6N114K M)+ M1>?'T1H+5Y.MY`=:Z[+S>166BTQC'$LPV>%U#K;8HNI-59L"X&:T`\)UK?8B MF3X,)E"0M_]%`2&?MSK?,K>X7#+>"*C[VNK)T:3'[>!O2P>M:HDLDQ/%:3!Q M:5NTX76VYQ3G7V-)R_2=DZVSI6%'.0;!:O*S8KRTJG[)A4O`VG>8Y:-M0^,Z M-Z-Z3X5W0^$;UZI#?-5RG`N^I2T1U]O'R3><%FV7-#=)X?9.5<2;%"I_D7H_ M;^JVJLF<+W\9&F#Z9G/&Y8WC6&WEQK3BRWXJ73%444Q1`)\XKD/5ZJI:^F$6 M2U>Y':2?1DOJ4SBZD*7EA?+;A,54OKTKI%0^J'?Y*-\=KE3)2*THEC$LTY)Z M4Z,-!FMS3=524I+YHC.=I7^9S&*C(A2#Y).IF;V;9^ZJ^6M01F'_`@U=8PTN M6:U79K"5\3C,I,ZT@$\<,YU1-<(4:_6;7V[QGT<,:%$RF*=`SC.>IWS5+)=Z MA']>Z`B=B%;NC6;5-1]T'>?;2W&F^@[\4&?`_\?F0C!HY8>%N(VGVL M]QD43MJ(2WSB%*^XQ2^.\8QK?.,<[[C'/P[RD(M\Y"0ONQZX>?7RJ=#!MJ9YCJ\\\L,E^L<6R[E.PGS+LWV:W@%4)SA'+'.IJ;+E@ MZPM./KN4H>Y%-9>Q"C6Z"U"DLK[SWMJ'=U.2F.U(P#D<]UA7+><,951?;HE7 M/$'U+C7(]\0G.ML<9U`WF?!+<%[F$RPV45.UGSW5L^91W6$^FUZ@BW_RX?>N M<\Y+X?.K[[;H70]ZS>.>RT#UZ'I=NEPCAQIIL'>X[(DEZ=;76=Z15^K?_7OW MO?L6^"%5O?,-JM#CWYRLWH9P-+%==F$7S]>S%*;XW:WAFG-?KG<=MQDOQFS# M:]\-;K]"ZHR_\__YWP%=8.`_2%&G?Q8":5O0>T&`?P'H!$7G!(@1FH@1O(@1WH@1]H=')V:27#7++D3C$G6]E38$#71)'?;F'6TKW?SF(43D':%QP+0U8@O8$A.]V6P4W2#@8>ZA%3\0W M!C_H`_,T7`(G=6JC5_3U>F>W3>M27R\V0^+T3(`%::*$2*"$4_^E36AV8:1& M?N\%>*95A66(5X!G>UX7;9Y$8;AF3)?5?*265'B(0%OF9'=(:WXV?5TE;9+7 MAT.V/NKD:>AW2&7G76:$WEAS.83H&X3'2X3'QH69(S:,=U7TIE=_[_0WF= MYGAZ5#9&V%"(-FK5YE=FMFVBZ%2-%V:G5FY-QF&3EF2558!R=XN_5&@)IFI2 M]5*,5FNL%X80\XF[1VF--(R--G/`N'M^IU(GA7V*HX>(Z&J]1WW!Z&BR&&;% MZ&>3EWRIIF>SQGO0QX2F-HL;%H[!5VK?:&O,I(.7M'X,"&WPUW4S)$-H-&SF MYXDX]DMS6%85!H8LU8]Y54-;]R$')I#39E=Y]6L..7:OEVWIMHK+QH#LE7+U MUR.8)'^O%9+&,Y+4`X(W58_5I01)9URQ%UQ1N$@G&81#.(1-QW,LZ)+.!9,H M*9.N4I+759-(]Y/(,I1L](!N%90]J91+R91-_^F43PF542F54TF552F411E* M/I>"D#.29`1S2;F3,1F#7&.)=2!<]\B5Z>5T(;B28*D)TK6608AX,`4M/Y>2 M<0"%-VF2-N"67=?D'>7F71R<#?0F#>ZE\ MGG:$,:B3O$!>IT\M1?<9@V;=-*L'D+59AE,.:.2/DXR6:9'Z9;V)>.W\F(B=@]\<6(FN9A MBNA&S#1DF5B;FRA\"O^5:URHB^R$39@X7SP6-V59B$5WB.4(9%F5=_^Y4;FV M?/IU:]B83F5&"Z7WB0\U4LLY@/T#9K<7>HO'>,*I3T/5F6[&CJ/WBR`V9\T( M41L*:LL(9MU'A0/5:LS(9J@XCH[TAI<'3R;:HIS)>Z^H>_Z$E:1`H1E4BA": MC,?(A.:)C,57BX&9I)UYI!EZI./G-=:4BS-Z>.)(BH/X:=,G@BTD--=(HV*V MA)!Y8U<(4*UFI:=G?:PV7&*ZIML95$8ZB/@AZGI+&BE/: MBI3GA/+(A^CX/YQFBAN#:^#8@QKZ8^@)J5QJHP;*:=CDI34(5>GIC7A&9E'_ M)0O[.)`-UG[N1IO.5*I$Q8]R:)VUY%<8Z8^_F)!UM9#FI9$UY6P9.6!R%6ZN M=&P'*6`DQ7"TZ:IHUZN^&FR$Y7U7-WY;B8\&%HVM^E^]I*MV%&'/!GZ_=E:R MBH9.-*0.J)A/H(J760@>R8MA:9./F9-"4*XM*0@LF5GRFEV+.8`K"9G790CT MBEGHVG-#Z:]MQVU&*9E0$+!6B;`)J[`+R[`-Z[`/"[$1*[$32[$5:[$7B[$9 MJ[$;R[%M\C,0*3VHY9:CQ9UGU)!T=:WYU[$"\USJ:J^A.7O:!9ASJ8,%J[`* MV%U*&)6S$+-U M>XJ0#)EVP/FM#(NS=9I!6]9NWUF$ANJ=(N:;^62FCJ>JOF2$WZ=XQ$F>1]6N M4-F59D.+--N+L85?.6=]Y%B*.^B8E=FV,MNW6G:W-LMVQP-\S*=[37NO-+M' M<`.(VBB$%WJFJMBFD@BV+[JU*[NXFC2U3UIS4G5[+$I0DIAF,EN9=#F-MAA] MA!NT4DM1D&M,B[:I?RNBL,>E-GBIB/AW--:AG!B[`N6*N^[PN_\2N_=/JX\_]K#"<;7.^JNO]ZG&:%1DG4G'*$;T=)O6=&P.%U MA&KYKW^I!D-TP*6DP'P9OG80HIBILH*9IXU[F(8)BON[70@<46HGR9H>49)>E5?59YD/*ON6:*IVV;RF9M.QLB2.IZ@;,A3W(QIVZ4[/,15QD]5 M!HWFR'*AU3&#.9ZJ%G*;51\E\:F//C+LU6L^I ML,X&3:;];(T:G7M@^K.S:XZF.&<8FLP;C;J^=\\EO:-F"JC2+#7NZ=(\BE6; MZZLQ3JL M!;FJN3J][&>%2&EG:WB1$8F\CIPX[+G5VL&#;6__A[S+J(;$V= MV"JLZ1=_5>V@<0V1*-NF97U67R5+7@W6W>K6`@<,#ARN3YBO(=?#@X#"+TL$ M^NMQB1T(#NRRAW38.M'0I^5OMRB2IZ58A-QY)=E:`$S`$5P&!TR^/U"RHI'# M-QRX2&C#-P@$JM7:-_S!UZQCB#P_)?^MGD3UMNDM M>KN8T3FUR+:,MH*JT]7XI74-TRF\-A<-I]<8MQ96S)+KM:0GX`KN-BG=W]:B M2"JZS?F,M^3\:&\K9XQZ?;VLC"_:.A3NXI=LS3-^G4A]=@X^XA1]WQF^3\[8 MCCJ*9A5^HBHMU%X;J?I-B%U6S!A=P*R3T3Z>TPTNY>%XT]3,R#Q>SOE]SX>Z MXR--W_2LIQW6B*8\T6,^.]DY=KUJK:>Y7_I(K4!ZD-J]MN]%D:G] M>]'6D!"'L\GK2EGMFL\;?FO,?DEMUE'-ME/XU6+MU!7);86]62+KWCPYEI=. M*_8;`[W_S=AI)2;+4IM?X2-I/ M[I<4&Y*.K:\U;+#[&W#Z]K'OV[542MN87MD^W+,:S*^W?8%$3.Y.ZV'#QEY/ MRYW'>+V"59U,WN=K!-6R"U.#;J5#;D<])JU?S93C;JLT#>')9\FBJ>4JQF$P MIO#?#,__^$R#2U-]6Y]ZU],]F>V6J:,@_^!_FW@%WCJFKVZC_[M$L'[DQ&L6N"]+^7N-;RK=V^WQ(3>L<__A.O@ON`SU* M.1^;@@O/]^GSA=RZ1*M^##^>K(O)-VOF4%_3_72*93[RXU3TKY;N4*S/7]Y6 M3$K4!EV5):O%S!W==.[40ROHUDO5JMF_Q$:0W6KQ*GC,Q.OW")G6:VWMRF[N MB#^ABI\+[,[X%.SJCR_YDT_YE6_YEX_YF:_YF\_YG>_Y;5G87EE&5RW`D+[` M+GGT>HO!SD66+(Z!'"SS['@S\ MJP^S`+C[$>CN#JWHK9R'F5MY9\V6`W?<;4R>*>C349U*Z*;5_7C4NQ1+V6V; M;D[O+RW>8B6!]5ZBN>CZECMI$%),WJV_K[`Z;)?&87#:?T6GUFBW^!;%79?&=RZ)V M+;WI3IW2I9Z6:,*J_IP0P^3\#.'FYNSZ5+HF';TLZ][:-CD[/3]!0T79-./R M'@4K&9>07%P'624;+QM;4Z$.:;UF`'59HE)5:PB#;6MO41FOR&OX M^;/3+EQ`>/3_8L2;MI!A0X`MJRJ-B,/V"\K;HNCT.Q4-/FI/DVZ0O"H!Q(%_,7E_CP4BJ!+P\),#G_Z^% M]*.75E`TLL@]>/N/2S(SK.\.)A4SA2<[7%3@TQM=OM>'62V2IQ736^'HP]9B1$ M#0UW7"U%[>7(5MN[=9A(*;$S&%7:;7*6ZM2JMLWO&FT7W%ZMK-5(0PU.6%U@ M5TV78%5)-'==B./$D]@X*T;87GBUE2+=+S&$M2:>?,X;L4`)G\4KR0?/02B?NF$QG.Z(+*CQ@;MN+5!SQJB MO4:V;)^%!C/`'G/_MBK7W3H"V*G#S\B5+<4+'TS6UC:"?*F7+)_..;,RC_SQ M*+6K?*R+S7CI<\]M8R[SF&C$E'7.1-.;)+U@+VSJKASL/';=J7(<]362\PZ$ M1*'+D03+[>9]A(8Q^]WYYTDY.,CA?7.,=>LZ2!X:@Y6#WOOOEZ=R19LK7(=/ M_Y"&8J\8"WUVP`;=6[M\H*']3,[XW5_R:?9]W\],3D-Z2E[WTY2^!&4QA#I.8Q33F,9&93&4NDYG- M=.8SH1E-:4ZSDK<+G9JN0TMJV.HQL]2FTE*#K4"ADIKE;)STKOD:XT5G-:7# M)'+6B3)SSK,A>09$2'-96H71WH]-RD0AW%RZ5,9=8XD0A#-(9U656=U8FV M!<>"E56A7K5K"8S:0S$BL69+K>I6;RJK">X"IHXRXF=B%D;`*E:-=W7L\9(7 M2!4%I#]2.UK9\O=(A?HE@`1MI%]X9A"YA;90=WO=.T+5-M&JK;+??.QK_3D7 M3?(0MK65"CF9HDK:VI;_MW:1BVZ%UUOA(F6V92FN?G`[7.4NE[G-=>YSH1M= MZ4Z7NM6U[G6QFUWM;I>[W?7N=\$;7O&.E[SE->]YT9M>]:Z7O>UU[WOA&U_Y MSI>^]=6IBYQ1X@,8RRRE#ZKQ0NN9HQ@L$Y&I"_M$(3G M__)3^AB\'6MIL<@0'-/%LIC(@H'0BUZ>QH(KRJU+.;!JW*2BPQ2M")Q-.JF" MM31J]Q8RTI%Y7XN^]+0B]:\4%O$@H&LKELWJ*?]9T-#;>V>94K4O+'-/$:J! M-16?"&JS?9K/FUM?GK%IZZ4&NM>W[@.<"ZIK4.D*9<0VZ9"M5N3A>9KHQLW@28W5"]HZE!+6\#MSC/F M4HTOBQT[AI-6]QPQ)VF:*CJE?\VWF_-J:SU_6M\&EW54%^YP7*.1WA0YG(X9 M[.0GGPBC=]2)B_!&OX\[>6_L0/)E:]SG0:ZZ;5'U\?^!_BC!)\=<1.71[(TX M.\FX)TH]=7Z3=I^M+C"^:J2!WJ5;?ZU;&> M=:UOG>M=]_K7P1YVL8^=[&4W^]G1GG:UKYWM;7?[VPVX2=Q$^R(^NE9Z9@G2)E7Y3SXGH+77>,]/'AE M[;.H>/VJAC7?G,@GGG*?%^*'Y;X\:I=>\"K./-TUOQS2;W[V&;YP:MX93]3G MD^^Q]WT9,!_*K26;?A2%FT6'M!Z$L@^2L2KU^.:^Y(W;F8-2;C:3'V3G4@=- MT(?JJ/I&>KZ+ MP5?0*HW@)X[V3HS-\H4/P(SEM4*@$7D`$AS8D& MZPLH\`:]9VH`3@;G2JSB*_&"N%D(>#\[.`J M)=5H3ZJT<-^RQ055B-CJ:HUPJ-_>+(NV\-_8#^9F"`,*46"]K`#0MI MSXVXQ5^4,$C\"EUPL%ZD1-S@C8%TQ=@:[F'BC=2R4`C[,&42[@@C9N$$YA"/ M#0FE_R7.:LV)E(T(?Z<-/3`'TVRC:$8.'[`(!^8+K5`4H8H2%Q$4)T9BK+`- MQ;`05]"F&HM>*O`,^2]D5L\#,9`'TRK;CLKAS#`95&:Q+*6P8*\W0.Z0YJ;_ M%"3DVH]NB@_D,BW__NO*](B0FM'Z2HO&6NMG,NIOF!'FEH;E"H2C5$YK[&^* MBB%M\J;X-NN@!`GF;,2TV(8=3:X^!H>RRK$:GZVS'JF/(`K\[`-J-DX9Y"8> M$>V6@F\H&C(B'I+Q`@_N5$]RGB(B8VL-*1+W+')QD@*X-K+S"G*_6`@@#B\9 M`6R;YG3TKDY*"&V;[2 M'K9O+&4G'ZOLBT)D`V-.`.5ORF3L%%Z2*2'B20YK!FE!:B8+`COQC+B!!

P$:T/C/1R3&QJA)RD&.G2)L@,,<>P%#VQW*H,,]_- MAZ@J%!-&JL;M8U9Q!$LQ%'E$8PH-J0BN,EOB,F.-XKP-!+LPC3S3?;J-K(+Q M$V,M">/0"?&HV%;/K]IJ7EI38ZX0-F="-@\Q%N_%-J\J+X,0L"M.RYAQ=I_^J\N?0 M49YZ#!O_LK34#!I+3L;NKR`5+QY+4!KSZ`/A$3U/`B-%8B:]*?L85+D3QU$Q7+/>RM"BA5+^\]$?W M3M0D2J32QJ'\!JM"I+/(#_\`,#W.PT\#$*1\#LHX;G[:KZ;TYO[P\<;R-"HA MB2S3,I`@_VHO06JBD(_0XK*UWG0;L41_YG`'?_&M:A$0>FJP'K&G)A,\/W5A M=O`"Q?#;:"JF4+&L)+,PD3$32/!_.K46EU38J`K2*E$0[5,TGW`.L75655/BJK-E')$O:5-/O?0$J3/,[A4/:;"'!5':6>$0.L?C1/N3%0`0D^1VH_6[8SE>\=FZ\_!31!![(]A[ZO^G!VD7A6 M-S?5)H-B2X>6NS@4%(SV:+,K:9762IF6NN:2(T9T\:+V:K$V:[5V:[FV:[WV M:\$V;,5V;,FV;,WV;-$V;=5V;=FV;=WV;>$V;N5V;NFV;NWV;O$V;_5V;_FV M;_WV;P$W<)\A``)`<%&T<`4`<0TW1!5W<1FT<1T7/2$W